title,datetime,link
Daiichi closes India facility in continued R&D overhaul,2017-01-12 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvRGFpaWNoaS1TYW5reW8tSW5kaWEtc3Vic2lkaWFyeS1yZXNlYXJjaC1jbG9zaW5nLzQzMzk0NS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Lilly shuffles management as new CEO signs on,2017-01-06 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbGlsbHktc2h1ZmZsZXMtbWFuYWdlbWVudC1hcy1uZXctY2VvLXNpZ25zLW9uLzQzMzQ5Ny_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"JPM: Valeant sells off Dendreon, skincare brands for $2.1B",2017-01-10 00:00:00,https://news.google.com/./articles/CBMiSGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvanBtLXZhbGVhbnQtZGVuZHJlb24tc2FucG93ZXIvNDMzNjgyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Amgen's Humira biosim clears EMA regulatory hurdle,2017-01-30 00:00:00,https://news.google.com/./articles/CBMiUWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvQ0hNUC1Ob3ZhcnRpcy1BbWdlbi1BbWpldml0YS1aaW94dGVuem8vNDM1MDU2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
J&J seals $30B deal for Actelion,2017-01-26 00:00:00,https://news.google.com/./articles/CBMiU2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvam5qLWFjdGVsaW9uLWFjcXVpcmUtZGVhbC0zMC1iaWxsaW9uLVBBSC80MzQ4Mzkv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Sanofi, Immunext partner to develop autoimmune therapies",2017-01-10 00:00:00,https://news.google.com/./articles/CBMiUWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2Fub2ZpLWltbXVuZXh0LUNEMTU0LUNENDBMLWF1dG9pbW11bmUvNDMzNzIxL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
7 companies to know in the emerging biosimilars field,2017-01-23 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvNy1jb21wYW5pZXMtdG8ta25vdy1pbi10aGUtZW1lcmdpbmctYmlvc2ltaWxhcnMtZmllbGQvNDMzNTM5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Payers balk at price of EpiPen rival,2017-01-25 00:00:00,https://news.google.com/./articles/CBMiQWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mva2FsZW8tYXV2aS1xLXBheWVyLXBibS80MzQ3NjUv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"RedHill, Concordia team up to market IBS drug",2017-01-03 00:00:00,https://news.google.com/./articles/CBMiT2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvUmVkSGlsbC1Db25jb3JkaWEtRG9ubmF0YWwtYWdyZWVtZW50LzQzMzIxNS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Report: Oncology, profitable drugs move to market faster, patent ...",2017-01-09 00:00:00,https://news.google.com/./articles/CBMiWWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvUXVpbnRpbGVzSU1TLWlubm92YXRpb24tbGlmZWN5Y2xlLXBhdGVudC1zYWxlcy80MzM2NDYv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Bird Rock one step closer to acquisition by J&J,2017-01-12 00:00:00,https://news.google.com/./articles/CBMiRGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmlyZC1yb2NrLWpvaG5zb24tamFuc3Nlbi80MzM4ODQv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"JPM: Saunders, Pops, others talk drug pricing",2017-01-10 00:00:00,https://news.google.com/./articles/CBMiUWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvanBtLWFsbGVyZ2FuLWpvaG5zb24taWNlci1kcnVnLXByaWNpbmcvNDMzNzc3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Anthem limits coverage for Biogen's new SMA drug,2017-01-24 00:00:00,https://news.google.com/./articles/CBMiTmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW50aGVtLWNvdmVyYWdlLXNwaW5yYXphLWJpb2dlbi1zbWEvNDM0NjY2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Gilead snaps up Sarepta's priority review voucher for $125M,2017-02-21 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2FyZXB0YS1wcmlvcml0eS1yZXZpZXctdm91Y2hlci1naWxlYWQtc2FsZS0xMjUvNDM2NTcyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Baxalta pushes Shire to record revenues,2017-02-16 00:00:00,https://news.google.com/./articles/CBMiUmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmF4YWx0YS1wdXNoZXMtc2hpcmUtdG8tcmVjb3JkLXJldmVudWVzLzQzNjM3OS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Sanofi sells off OTC products to Ipsen,2017-02-14 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaXBzZW4tc2Fub2ZpLWRpdmVzdC1jb25zdW1lci1oZWFsdGhjYXJlLXNhbGUvNDM2MTM2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Prescribed Reading: When will Gilead tap its cash hoard?,2017-02-10 00:00:00,https://news.google.com/./articles/CBMiZGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZ2lsZWFkLWRlYWxzLXByaWNpbmctbHVuZGJhY2stbWFyYXRob24tcHJlc2NyaWJlZC1yZWFkaW5nLzQzNTk2NC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Merck unveils new Keytruda DTC ad,2017-02-01 00:00:00,https://news.google.com/./articles/CBMiTGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWVyY2stdW52ZWlscy1uZXcta2V5dHJ1ZGEtZHRjLWFkLzQzNTI3MC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
EMA reviews Actelion PAH drug after patient deaths,2017-02-15 00:00:00,https://news.google.com/./articles/CBMiXWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZW1hLXJldmlld3MtYWN0ZWxpb24tcGFoLWRydWctYWZ0ZXItcGF0aWVudC1kZWF0aHMvNDM2MjI2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
How biomarkers cost Bristol-Myers the lung cancer market,2017-02-13 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmlvbWFya2Vycy1icmlzdG9sLW15ZXJzLW9wZGl2by1sb3N0LWx1bmctY2FuY2VyLzQzNTg5MS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Neurocrine enters licensing deal for Parkinson's drug,2017-02-10 00:00:00,https://news.google.com/./articles/CBMiUmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbmV1cm9jcmluZS1iaWFsLW9uZ2VudHlzLWxpY2Vuc2luZy1kZWFsLzQzNTk2Ny_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Pfizer, Celltrion pushing for interchangeability with Inflectra",2017-02-22 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaW5mbGVjdHJhLXJlbWljYWRlLWludGVyY2hhbmdlYWJsZS1QZml6ZXItSk5KLXJlc3VsdHMvNDM2NjgxL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
PhRMA launches Go Boldly's first science dialogue,2017-02-22 00:00:00,https://news.google.com/./articles/CBMiUGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGhybWEtZ28tYm9sZGx5LWRydWctcHJpY2luZy1kaWFsb2d1ZS80MzY2Nzkv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Generics trade group rebrands, emphasizing 'accessible' medicines",2017-02-15 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZ2VuZXJpYy1ncGhhLXJlYnJhbmQtYWNjZXNzaWJsZS1tZWRpY2luZXMtZHJ1Z3MvNDM2Mjc3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Novo Nordisk waffles due to US political uncertainty,2017-02-02 00:00:00,https://news.google.com/./articles/CBMiT2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92by1ub3JkaXNrLWVhcm5pbmdzLWRpYWJldGVzLXRydW1wLzQzNTM1OC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Kaleo faces political pressure over drug price hikes,2017-02-06 00:00:00,https://news.google.com/./articles/CBMiUGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mva2FsZW8tZHJ1Zy1wcmljaW5nLW5hbG94b25lLWtsb2J1Y2hhci80MzU1NTAv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Dar√© hoping to turn Cerulean from blue to black,2017-03-21 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZGFyZS1ob3BpbmctdG8tdHVybi1jZXJ1bGVhbi1mcm9tLWJsdWUtdG8tYmxhY2svNDM4NTg2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Seres rekindles once-failed microbiome study,2017-03-17 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2VyZXMtcmVraW5kbGVzLW9uY2UtZmFpbGVkLW1pY3JvYmlvbWUtc3R1ZHkvNDM4MzY2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Sanofi, Regeneron's eczema drug Dupixent gains FDA approval",2017-03-28 00:00:00,https://news.google.com/./articles/CBMiUWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2Fub2ZpLXJlZ2VuZXJvbi1kdXBpeGVudC1GREEtYXBwcm92YWwvNDM5MTU5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Under fire, Marathon offloads Duchenne drug to PTC for $140M",2017-03-16 00:00:00,https://news.google.com/./articles/CBMiVGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcHRjLW1hcmF0aG9uLWVtZmxhemEtZG1kLWRydWctMTQwLW1pbGxpb24vNDM4MjYwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Serenity wins FDA nod on frequent nighttime urination treatment,2017-03-08 00:00:00,https://news.google.com/./articles/CBMiamh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2VyZW5pdHktd2lucy1mZGEtbm9kLW9uLWZyZXF1ZW50LW5pZ2h0dGltZS11cmluYXRpb24tdHJlYXRtZW50LzQzNzY2Mi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Amgen's Repatha shows CV benefit, but falls short of expectations",2017-03-17 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW1nZW4tZm91cmllci1yZXBhdGhhLXBjc2s5LWNhcmRpb3Zhc2N1bGFyLW91dGNvbWVzLzQzODM2Mi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
$5B in Humira sales at stake with Amgen EU approval,2017-03-24 00:00:00,https://news.google.com/./articles/CBMiXWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvNWItaW4taHVtaXJhLXNhbGVzLWF0LXN0YWtlLXdpdGgtYW1nZW4tZXUtYXBwcm92YWwvNDM4ODc1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
FDA warns of Viberzi pancreatitis risk,2017-03-17 00:00:00,https://news.google.com/./articles/CBMiUWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLXdhcm5zLW9mLXZpYmVyemktcGFuY3JlYXRpdGlzLXJpc2svNDM4MzMxL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Report: Why Merck turned to supply chain integration to save costs,2017-03-02 00:00:00,https://news.google.com/./articles/CBMibGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcmVwb3J0LXdoeS1tZXJjay10dXJuZWQtdG8tc3VwcGx5LWNoYWluLWludGVncmF0aW9uLXRvLXNhdmUtY29zdHMvNDM3MjkwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"5 biotech CEOs on payers, investors and big bets",2017-03-09 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvNS1iaW90ZWNoLWNlb3Mtb24tcGF5ZXJzLWludmVzdG9ycy1hbmQtYmlnLWJldHMvNDM3NzcxL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
How DTC got things moving for Linzess,2017-03-01 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaXJvbndvb2QtbWFya2V0aW5nLWxpbnplc3MtY2FtcGFpZ24tY29uc3RpcGF0aW9uLzQzNzA5NC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Samsung Bioepis beats AbbVie in UK patent court,2017-03-06 00:00:00,https://news.google.com/./articles/CBMiSmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvU2Ftc3VuZy1hYmJ2aWUtaHVtaXJhLXBhdGVudC11ay80Mzc0ODAv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Pressure builds on Marathon over orphan drug price,2017-03-07 00:00:00,https://news.google.com/./articles/CBMiX2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWFyYXRob24tY29uZ3Jlc3MtbGV0dGVyLWVtZmxhemEtZHJ1Zy1wcmljZS1zY3J1dGlueS80Mzc1NjAv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Using social to tap into the rare disease market,2017-03-10 00:00:00,https://news.google.com/./articles/CBMiT2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdGFwcGluZy1pbnRvLXRoZS1yYXJlLWRpc2Vhc2UtbWFya2V0LzQzNzgwNS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Newron finally secures US approval for Parkinson's drug,2017-03-22 00:00:00,https://news.google.com/./articles/CBMiUGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbmV3cm9uLXBhcmtpbnNvbnMteGFkYWdvLWZkYS1hcHByb3ZhbC80Mzg2ODMv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Lilly offers up drug pricing details amid ongoing scrutiny of industry,2017-03-20 00:00:00,https://news.google.com/./articles/CBMiQ2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvRWxpLWxpbGx5LXByaWNpbmctcmVwb3J0LzQzODQ3NC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
JAMA confirms DTC drove 'Low-T' craze,2017-03-23 00:00:00,https://news.google.com/./articles/CBMiRGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvamFtYS1kdGMtdGVzdG9zdGVyb25lLWFkcy80Mzg3ODYv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Bernie Sanders calls for more broadcast news on drug pricing,2017-03-15 00:00:00,https://news.google.com/./articles/CBMiR2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2FuZGVycy1kcnVnLXByaWNpbmctdHYtbmV3cy80MzgxNTMv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"OncBioMune, EOC aim to develop gastric cancer drug",2017-03-15 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvb25jYmlvbXVuZS1lb2MtYWltLXRvLWRldmVsb3AtZ2FzdHJpYy1jYW5jZXItZHJ1Zy80MzgxNTcv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"J&J, GSK pull ads from YouTube amid display concerns",2017-03-23 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvam9obnNvbi1qb2huc29uLWdzay1zdG9wLWFkdmVydGlzaW5nLWdvb2dsZS15b3V0dWJlLzQzODc5NS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
FDA gives go-ahead to Lexicon's rare disease drug,2017-03-01 00:00:00,https://news.google.com/./articles/CBMiTWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbGV4aWNvbnMtcmFyZS1kaXNlYXNlLWZkYS1hcHByb3ZhbC80MzcxNzkv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Allergan eyes up dry eye patients,2017-03-01 00:00:00,https://news.google.com/./articles/CBMiTGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWxsZXJnYW4tZXllcy11cC1kcnktZXllLXBhdGllbnRzLzQzNzEzNi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"MS drugs too expensive, ICER says",2017-03-07 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaWNlci1tdWx0aXBsZS1zY2xlcm9zaXMtZHJ1Zy1wcmljZS1leHBlbnNpdmUvNDM3NjE4L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Amid sales growth, Roche plans defense from biosimilar threats",2017-04-27 00:00:00,https://news.google.com/./articles/CBMiaGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW1pZC1zYWxlcy1ncm93dGgtcm9jaGUtcGxhbnMtZGVmZW5zZS1mcm9tLWJpb3NpbWlsYXItdGhyZWF0cy80NDE0MDIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
RedHill acquires rights to medical food from Entera Health,2017-04-05 00:00:00,https://news.google.com/./articles/CBMiS2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvUmVkSGlsbC1FbnRlcmEtZGVhbC1tZWRpY2FsLWZvb2QvNDM5ODE3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Neurocrine's Ingrezza secures FDA approval,2017-04-12 00:00:00,https://news.google.com/./articles/CBMiS2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbmV1cm9jcmluZS1mZGEtYXBwcm92YWwtaW5ncmV6emEvNDQwMzU1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
CytRx set to file cancer drug NDA,2017-04-19 00:00:00,https://news.google.com/./articles/CBMiRmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvQ3l0UngtTkRBLUZEQS1hbGRveG9ydWJpY2luLzQ0MDc5Mi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
AbbVie's PARP inhibitor fails two late-stage cancer trials,2017-04-20 00:00:00,https://news.google.com/./articles/CBMiZGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWJidmllcy1wYXJwLWluaGliaXRvci1mYWlscy10d28tbGF0ZS1zdGFnZS1jYW5jZXItdHJpYWxzLzQ0MDkwMi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"High prices shock Japan, prompting dramatic changes",2017-04-19 00:00:00,https://news.google.com/./articles/CBMiXWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaGlnaC1wcmljZXMtc2hvY2stamFwYW4tcHJvbXB0aW5nLWRyYW1hdGljLWNoYW5nZXMvNDQwNDc2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Scott Gottlieb commits to defend FDA's 'gold standard' for drug reviews,2017-04-05 00:00:00,https://news.google.com/./articles/CBMib2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2NvdHQtZ290dGxpZWItY29tbWl0cy10by1kZWZlbmQtZmRhcy1nb2xkLXN0YW5kYXJkLWZvci1kcnVnLXJldmlld3MvNDM5ODI1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Sanofi missed out on EpiPen and it's not happy,2017-04-26 00:00:00,https://news.google.com/./articles/CBMiUmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbXlsYW4ta2FsZW8tc2Fub2ZpLWF1dmlxLWVwaXBlbi1sYXdzdWl0LzQ0MTMyNi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Biogen underscores Ocrevus' threat to MS revenues,2017-04-25 00:00:00,https://news.google.com/./articles/CBMiVWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvb2NyZXZ1cy1iaW9nZW4tbXVsdGlwbGUtc2NsZXJvc2lzLXJldmVudWVzLzQ0MTI0Ny_SAQA?hl=en-US&gl=US&ceid=US%3Aen
What pharma needs to know about local healthcare markets,2017-04-11 00:00:00,https://news.google.com/./articles/CBMiZGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL3Nwb25zL3doYXQtcGhhcm1hLW5lZWRzLXRvLWtub3ctYWJvdXQtbG9jYWwtaGVhbHRoY2FyZS1tYXJrZXRzLzQzOTYwOC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
PhRMA takes shot at payers in drug pricing war,2017-04-06 00:00:00,https://news.google.com/./articles/CBMiUmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGhybWEtcGF5ZXJzLWFkLWNhbXBhaWduLWRpc2NvdW50cy1kcnVnLzQzOTkxNy_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Amgen optimistic despite sales saying otherwise,2017-04-27 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW1nZW4tZW5icmVsLWRlY2xpbmUtcXVhcnRlci1lYXJuaW5ncy1yZXBhdGhhLzQ0MTQwNS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
BioMarin's Batten disease drug gets a yes at a cost of $702K,2017-04-28 00:00:00,https://news.google.com/./articles/CBMiZWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmlvbWFyaW5zLWJhdHRlbi1kaXNlYXNlLWRydWctZ2V0cy1hLXllcy1hdC1hLWNvc3Qtb2YtNzAyay80NDE1Mjgv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Market forces push uniQure to abandon Glybera,2017-04-20 00:00:00,https://news.google.com/./articles/CBMiT2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdW5pcXVyZS1nbHliZXJhLWFiYW5kb24tZ2VuZS10aGVyYXB5LzQ0MDkwMS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Valeant prices psoriasis drug at $42K per year,2017-04-21 00:00:00,https://news.google.com/./articles/CBMiSmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvVmFsZWFudC1TaWxpcS1wcmljaW5nLXBzb3JpYXNpcy80NDEwMDEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"In familiar routine, ICER finds rheumatoid arthritis drugs overpriced",2017-04-10 00:00:00,https://news.google.com/./articles/CBMiTGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaWNlci1hcnRocml0aXMtZHJ1Z3MtcHJpY2UtcmVwb3J0LzQ0MDE0NS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Minerva's schizophrenia drug heads to late stages,2017-05-16 00:00:00,https://news.google.com/./articles/CBMiTGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvTWluZXJ2YS1zY2hpem9waHJlbmlhLVBoYXNlLTMtRkRBLzQ0MjgyMi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
J&J puts $1B on the line for success of Protagonist drug,2017-05-30 00:00:00,https://news.google.com/./articles/CBMiYWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvamotcHV0cy0xYi1vbi10aGUtbGluZS1mb3Itc3VjY2Vzcy1vZi1wcm90YWdvbmlzdC1kcnVnLzQ0Mzc5Ny_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Novartis axing 250 US positions in data operations move,2017-05-25 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92YXJ0aXMtYXhpbmctMjUwLXVzLXBvc2l0aW9ucy1pbi1kYXRhLW9wZXJhdGlvbnMtbW92ZS80NDM1ODQv0gEA?hl=en-US&gl=US&ceid=US%3Aen
FDA casts doubts on Intra-Cellular safety data,2017-05-02 00:00:00,https://news.google.com/./articles/CBMiWWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLWNhc3RzLWRvdWJ0cy1vbi1pbnRyYS1jZWxsdWxhci1zYWZldHktZGF0YS80NDE3NjIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
FDA rejection sets back TherapeuticsMD,2017-05-09 00:00:00,https://news.google.com/./articles/CBMiUWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLXJlamVjdGlvbi1zZXRzLWJhY2stdGhlcmFwZXV0aWNzbWQvNDQyMjU1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Can value-based deals work if patients don't take the drug?,2017-05-15 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWRoZXJlbmNlLXZhbHVlLWJhc2VkLWRlYWwtcGF5bWVudC1wYXRpZW50LW91dGNvbWVzLzQ0MjQ0OS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Senate confirms Scott Gottlieb as FDA chief,2017-05-10 00:00:00,https://news.google.com/./articles/CBMiUGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZ290dGxpZWItZmRhLXNlbmF0ZS1jb25maXJtYXRpb24tdm90ZS80NDI0Mjgv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Sanofi joins pharma pricing pledge ranks,2017-05-09 00:00:00,https://news.google.com/./articles/CBMiRWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2Fub2ZpLWRydWctcHJpY2luZy1wbGVkZ2UvNDQyMjk3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
5 trends changing drug adherence for the better,2017-05-15 00:00:00,https://news.google.com/./articles/CBMiS2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2hhbmdpbmctZHJ1Zy1hZGhlcmVuY2UtNS10cmVuZHMvNDQyNTQ0L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Express Scripts, GoodRx roll out cost savings program",2017-05-08 00:00:00,https://news.google.com/./articles/CBMiX2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZXhwcmVzcy1zY3JpcHRzLWdvb2RyeC1yb2xsLW91dC1jb3N0LXNhdmluZ3MtcHJvZ3JhbS80NDIxOTcv0gEA?hl=en-US&gl=US&ceid=US%3Aen
PhRMA ousts 22 drugmakers from ranks in membership change,2017-05-10 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGhybWEtbWVtYmVyc2hpcC1jaGFuZ2VzLTIyLWRydWdtYWtlcnMtcmVzZWFyY2gvNDQyNDAyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
EU investigating generic drugmaker over cancer drug price hikes,2017-05-15 00:00:00,https://news.google.com/./articles/CBMiZ2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYXNwZW4tcGhhcm1hLWFudGl0cnVzdC1nZW5lcmljLWRydWdzLUVDLWV1cm9wZS1pbnZlc3RpZ2F0aW9uLzQ0MjcyMi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Weak Xtandi sales spur questions on Pfizer's $14B Medivation ...,2017-05-03 00:00:00,https://news.google.com/./articles/CBMiVmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGZpemVyLXh0YW5kaS1zbG93LXNhbGVzLXBhdGllbnQtYXNzaXN0YW5jZS80NDE4OTMv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Merck, UnitedHealth explore improving value-based contracts",2017-05-26 00:00:00,https://news.google.com/./articles/CBMiZWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWVyY2stdW5pdGVkaGVhbHRoLWV4cGxvcmUtaW1wcm92aW5nLXZhbHVlLWJhc2VkLWNvbnRyYWN0cy80NDM2OTAv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Merck sees Keytruda gains, offsetting generic hits to sales",2017-05-02 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWVyY2sta2V5dHJ1ZGEtbHVuZy1jYW5jZXItZWFybmluZ3MtZmlyc3QtcXVhcnRlci80NDE3NjAv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Payer, consumer pushback expected to dampen drug spending ...",2017-05-04 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvUXVpbnRpbGVzSU1TLXByaWNpbmctcHJlc3N1cmVzLWRydWctc3BlbmRpbmcvNDQxOTg2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
PTC to launch DMD drug with still-high price tag,2017-05-09 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcHRjLXRvLWxhdW5jaC1kbWQtZHJ1Zy13aXRoLXN0aWxsLWhpZ2gtcHJpY2UtdGFnLzQ0MjI4Ny_SAQA?hl=en-US&gl=US&ceid=US%3Aen
EMA recommends 11 drugs for approval in May meeting,2017-05-22 00:00:00,https://news.google.com/./articles/CBMiU2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2htcC1wb3NpdGl2ZS1vcGluaW9uLXp5a2FkaWEtYnJvZGFsdW1hYi80NDMyNjYv0gEA?hl=en-US&gl=US&ceid=US%3Aen
FDA gives thumbs up to Takeda's lung cancer drug,2017-05-01 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLWdpdmVzLXRodW1icy11cC10by10YWtlZGFzLWx1bmctY2FuY2VyLWRydWcvNDQxNjUzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Roche looks into PML report for Ocrevus patient,2017-05-25 00:00:00,https://news.google.com/./articles/CBMiT2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvcm9jaGUtcG1sLW9jcmV2dXMtbXVsdGlwbGUtc2NsZXJvc2lzLzQ0MzU2OC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Patient centricity is important, but customer centricity is imperative",2017-05-18 00:00:00,https://news.google.com/./articles/CBMicWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL3Nwb25zL3BhdGllbnQtY2VudHJpY2l0eS1pcy1pbXBvcnRhbnQtYnV0LWN1c3RvbWVyLWNlbnRyaWNpdHktaXMtaW1wZXJhdGl2ZS80NDE5MDIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Novartis set to ride Entresto wave, says report",2017-05-15 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92YXJ0aXMtZW50cmVzdG8tc2FsZXMtYWNjZWxlcmF0aW9uLXVwdGFrZS1qZWZmZXJpZXMvNDQyNzI3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Endocyte slumps on staff and R&D cuts,2017-06-06 00:00:00,https://news.google.com/./articles/CBMiT2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZW5kb2N5dGUtc2x1bXBzLW9uLXN0YWZmLWFuZC1yZC1jdXRzLzQ0NDMyMy_SAQA?hl=en-US&gl=US&ceid=US%3Aen
CHMP decisions: Novartis locks up backing for Kisqali,2017-06-23 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92YXJ0aXMta2lzcWFsaS1lbWEtY2htcC1yZWNvbW1lbmRhdGlvbi1hdmVvLXRpdm96YW5pYi80NDU3NDUv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Lilly drops $55M for access to new class of diabetes drugs,2017-06-08 00:00:00,https://news.google.com/./articles/CBMiZGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbGlsbHktZHJvcHMtNTVtLWZvci1hY2Nlc3MtdG8tbmV3LWNsYXNzLW9mLWRpYWJldGVzLWRydWdzLzQ0NDU3MS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
ASCO17: CAR-Ts steal the show,2017-06-06 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmx1ZWJpcmQtbGVnZW5kLWNhci10LWJjbWEtbXVsdGlwbGUtbXllbG9tYS1hc2NvLzQ0NDI3OS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
5 Trends affecting gene therapy development,2017-06-12 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdHJlbmRzLWdlbmUtdGhlcmFweS1kcnVnLWRldmVsb3BtZW50LXByaWNlLXBhdGVudC80NDQyNjAv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"ASCO17: Roche's Perjeta cuts risk in Aphinity, but is it enough?",2017-06-05 00:00:00,https://news.google.com/./articles/CBMiWWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvcm9jaGUtYXBoaW5pdHktcGVyamV0YS1oZXJjZXB0aW4tYnJlYXN0LWNhbmNlci80NDQxNjIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
EpiPen alternative Symjepi gets FDA OK,2017-06-16 00:00:00,https://news.google.com/./articles/CBMiWWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWRhbWlzLWZkYS1hcHByb3ZhbC1lcGlwZW4tYWx0ZXJuYXRpdmUtc3ltamVwaS80NDUyMTcv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Pfizer, Roche, Aspen under investigation for cancer drug pricing",2017-06-14 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGZpemVyLXJvY2hlLWFzcGVuLWNhbmNlci1wcmljaW5nLWludmVzdGlnYXRpb24vNDQ1MDA0L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"AbbVie, Novo, Takeda have best reputations in pharma, new study ...",2017-06-02 00:00:00,https://news.google.com/./articles/CBMiTWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcmVwdXRhdGlvbi1waGFybWEtaW5zdGl0dXRlLXJlcG9ydC80NDQxMTQv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Novartis anti-inflammatory drug locks down landmark results in CV ...,2017-06-22 00:00:00,https://news.google.com/./articles/CBMiVWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92YXJ0aXMtY2FuYWtpbnVtYWItaWxhcmlzLWhlYXJ0LWN2LXN0dWR5LzQ0NTYyMi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Shire's ADHD drug secures FDA OK,2017-06-21 00:00:00,https://news.google.com/./articles/CBMiSmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2hpcmVzLWFkaGQtZHJ1Zy1zZWN1cmVzLWZkYS1vay80NDU1MzIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Rebates not to blame for rising drug costs, says PBM trade group",2017-06-14 00:00:00,https://news.google.com/./articles/CBMiVmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZHJ1Zy1wcmljZS1yZWJhdGUtcGNtYS1yZXBvcnQtcGF5ZXJzLXBoYXJtYS80NDQ5OTgv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Humira shows its staying power,2017-06-19 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGZpemVyLXhlbGphbnotaHVtaXJhLWhlYWQtdG8taGVhZC1hcnRocml0aXMvNDQ1MzA3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Clarus resubmits oral hormone therapy to FDA,2017-06-27 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2xhcnVzLXJlc3VibWl0cy1vcmFsLWhvcm1vbmUtdGhlcmFweS10by1mZGEvNDQ1OTQyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
GSK looks to exit rare diseases,2017-07-27 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZ2xheG9zbWl0aGtsaW5lLWdzay1yYXJlLWRpc2Vhc2Utc2VsbC1kaXZlc3Qtc3RyaW12ZWxpcy80NDgwODcv0gEA?hl=en-US&gl=US&ceid=US%3Aen
FDA panel unanimously backs approval of Novartis CAR-T,2017-07-12 00:00:00,https://news.google.com/./articles/CBMiU2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92YXJ0aXMtY2FyLXQtY3RsMDE5LWZkYS1hZGNvbW0tc3VwcG9ydC80NDY5MjUv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Biogen: 'Our goal is to be that leader',2017-07-25 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmlvZ2VuLXNlY29uZC1xdWFydGVyLXNwaW5yYXphLXRlY2ZpZGVyYS1uZXVyb3NjaWVuY2UvNDQ3ODEwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Novartis taps Cryoport for CAR-T logistics support,2017-07-27 00:00:00,https://news.google.com/./articles/CBMiZmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92YXJ0aXMtY3J5b3BvcnQtY2FyLXQtbG9naXN0aWNzLXNoaXBwaW5nLWNyeW9wcmVzZXJ2YXRpb24vNDQ4MDYwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"BioMarin, Spark, raising the stakes for hemophilia",2017-07-12 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaGVtb3BoaWxpYS1JU1RILXNwYXJrLWFsbnlsYW0tZ2VuZS10aGVyYXB5LWJpb21hcmluLzQ0Njg0OS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Lilly extends patent runway for Cialis,2017-07-13 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbGlsbHktY2lhbGlzLXBhdGVudC1nZW5lcmljLWNvcHljYXQtc2V0dGxlbWVudC0yMDE4LzQ0NzAyMC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Kadmon ROCKing some positive results,2017-07-12 00:00:00,https://news.google.com/./articles/CBMiT2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mva2FkbW9uLXJvY2tpbmctc29tZS1wb3NpdGl2ZS1yZXN1bHRzLzQ0NjkwNi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Celgene makes play to strengthen PD-1 position,2017-07-06 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2VsZ2VuZS1iZWlnZW5lLXBkLTEtaW5oaWJpdG9yLWRlYWwtaW1tdW5vLW9uY29sb2d5LzQ0NjQ4Ny_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Amid industry-wide pricing backlash, Vertex raises Orkambi cost",2017-07-05 00:00:00,https://news.google.com/./articles/CBMiUmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdmVydGV4LW9ya2FtYmktcHJpY2UtaW5jcmVhc2UtbGlzdC1jb3N0LzQ0NjQxNi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Industry paid $8.2B to docs, hospitals last year",2017-07-05 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGhhcm1hLW9wZW4tcGF5bWVudHMtZG9jdG9ycy1jbXMtcmVzZWFyY2gtZHJ1Z3MvNDQ2Mzk0L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
PhRMA finally talks drug pricing in new campaign,2017-07-19 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGhybWEtZmluYWxseS10YWxrcy1kcnVnLXByaWNpbmctaW4tbmV3LWNhbXBhaWduLzQ0NzQ2Mi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Generic drug association sues to stop state price-gouging law,2017-07-07 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZ2VuZXJpYy1hc3NvY2lhdGlvbi1sYXdzdWl0LW1hcnlsYW5kLWRydWctcHJpY2UtbGF3LWFhbS80NDY2MTUv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Celgene pays $280M to make fraud allegations go away,2017-07-26 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2VsZ2VuZS1wYXlzLTI4MG0tdG8tbWFrZS1mcmF1ZC1hbGxlZ2F0aW9ucy1nby1hd2F5LzQ0NzkzMi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Novartis hits pause on Fovista agreement,2017-07-10 00:00:00,https://news.google.com/./articles/CBMiYWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92YXJ0aXMtb3BodGhvdGVjaC1mb3Zpc3RhLWxpY2Vuc2luZy1sZXR0ZXItYWdyZWVtZW50LzQ0NjcxMi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Endo caves to FDA pressure, removes Opana from market",2017-07-06 00:00:00,https://news.google.com/./articles/CBMiUGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZW5kby1vcGFuYS1lci1yZW1vdmUtcHVsbHMtbWFya2V0LWZkYS80NDY1MjMv0gEA?hl=en-US&gl=US&ceid=US%3Aen
J&J: Remicade holding up better than expected,2017-07-18 00:00:00,https://news.google.com/./articles/CBMiUmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvam9obnNvbi1xMi1lYXJuaW5ncy1yZW1pY2FkZS1iaW9zaW1pbGFyLzQ0NzM0NS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Merck undercuts Pfizer on Remicade biosimilar price,2017-07-26 00:00:00,https://news.google.com/./articles/CBMiX2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWVyY2stbGF1bmNoLXJlbWljYWRlLWJpb3NpbWlsYXItZGlzY291bnQtam5qLXBmaXplci80NDc5Mzkv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"J&J's Tremfya approved, further crowding IL-inhibitor market",2017-07-14 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvam9obnNvbi10cmVtZnlhLWFwcHJvdmFsLUlMLWluaGliaXRvci1tYXJrZXQvNDQ3MTQ5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
AbbVie faces $150M in damages in AndroGel trial,2017-07-26 00:00:00,https://news.google.com/./articles/CBMiWWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWJidmllLWZhY2VzLTE1MG0taW4tZGFtYWdlcy1pbi1hbmRyb2dlbC10cmlhbC80NDc5MzUv0gEA?hl=en-US&gl=US&ceid=US%3Aen
GSK gets go-ahead for new Benlysta formulation,2017-07-26 00:00:00,https://news.google.com/./articles/CBMiXWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZ2xheG9zbWl0aGtsaW5lLWdzay1iZW5seXN0YS1zdWJjdXRhbmVvdXMtYXBwcm92YWwvNDQ3OTUxL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Allergan conflicted about teenage Botox market in light of growing ...,2017-07-12 00:00:00,https://news.google.com/./articles/CBMiSGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWxsZXJnYW4tdGVlbmFnZS1ib3RveC1tYXJrZXQvNDQ2OTMyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Ironwood wins FDA approval for combo gout drug,2017-08-21 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaXJvbndvb2QtZHV6YWxsby1hcHByb3ZhbC1nb3V0LWRydWctaHlwZXJ1cmljZW1pYS81MDMwOTYv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Novogen irons out Phase 2 plans for brain cancer candidate,2017-08-22 00:00:00,https://news.google.com/./articles/CBMiZWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92b2dlbi1pcm9ucy1vdXQtcGhhc2UtMi1wbGFucy1mb3ItYnJhaW4tY2FuY2VyLWNhbmRpZGF0ZS81MDMyMzcv0gEA?hl=en-US&gl=US&ceid=US%3Aen
The secret recipe behind the launch price of a drug,2017-08-14 00:00:00,https://news.google.com/./articles/CBMiUmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZHJ1Zy1wcmljaW5nLXJlY2lwZS1sYXVuY2gtcHJpY2Utc2Fub2ZpLzQ0OTAwNC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"MedCo gets FDA OK on antibacterial, boosting sale potential",2017-08-30 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWVkaW5jaW5lcy1jb21wYW55LWFudGliYWN0ZXJpYWwtZmRhLWFwcHJvdmFsLzUwMzg4Mi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Zynerba shares up in smoke after trial failure,2017-08-07 00:00:00,https://news.google.com/./articles/CBMiYWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvenluZXJiYS1jbGluaWNhbC10cmlhbC1mYWlsdXJlLWNhbm5hYmlub2lkLXNoYXJlcy1kcm9wLzQ0ODc3MS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Alexion bolsters Soliris patent defense,2017-08-16 00:00:00,https://news.google.com/./articles/CBMiUmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWxleGlvbi1ib2xzdGVycy1zb2xpcmlzLXBhdGVudC1kZWZlbnNlLzQ0OTQ3Ni_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Idhifa approval furthers Celgene's diversification goals,2017-08-01 00:00:00,https://news.google.com/./articles/CBMiTGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2VsZ2VuZS1pZGhpZmEtYXBwcm92YWwtYWdpb3MtYW1sLzQ0ODM4MC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Adamas Parkinson's drug gains FDA approval,2017-08-25 00:00:00,https://news.google.com/./articles/CBMiVGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWRhbWFzLXBhcmtpbnNvbnMtZHJ1Zy1nYWlucy1mZGEtYXBwcm92YWwvNTAzNTE0L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"As Roche wades biosimilar waters, more competitors circle Herceptin",2017-08-02 00:00:00,https://news.google.com/./articles/CBMiUmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvUm9jaGUtaGVyY2VwdGluLWJpb3NpbWlsYXItbXlsYW4tYmlvY29uLzQ0ODQ3Mi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
5 Trends influencing drug pricing,2017-08-14 00:00:00,https://news.google.com/./articles/CBMiUWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdHJlbmRzLWRydWctcHJpY2luZy1waGFybWEtcGF5ZXJzLWNvc3QvNDQ4Nzc5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"In cost debate, Amgen stands by Repatha's value",2017-08-23 00:00:00,https://news.google.com/./articles/CBMiVWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW1nZW4tcmVwYXRoYS1zdHVkeS1wY3NrOS12YWx1ZS1jb3N0LXByaWNlLzUwMzMwMi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"PCSK9 inhibitors still too pricey, study finds",2017-08-22 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW1nZW4tcmVwYXRoYS1wY3NrOS1jb3N0LWVmZmVjdGl2ZW5lc3MtamFtYS1zdHVkeS81MDMyMDEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Cardiome shaken by FDA no-go on heart drug refiling,2017-08-22 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2FyZGlvbWUtc2hha2VuLWJ5LWZkYS1uby1nby1vbi1oZWFydC1kcnVnLXJlZmlsaW5nLzUwMzIxNC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Puma's early Nerlynx launch raises doubts of a takeover,2017-08-01 00:00:00,https://news.google.com/./articles/CBMiYWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcHVtYXMtZWFybHktbmVybHlueC1sYXVuY2gtcmFpc2VzLWRvdWJ0cy1vZi1hLXRha2VvdmVyLzQ0ODM1OC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Expanded label boosts AstraZeneca and Merck's Lynparza,2017-08-18 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYXN0cmF6ZW5lY2EtbHlucGFyemEtYXBwcm92YWwtYnJvYWRlci1sYWJlbC1tYWludGVuYW5jZS80NDk2NTEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
ALK readies Odactra launch after Merck exit,2017-08-22 00:00:00,https://news.google.com/./articles/CBMiVmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWxrLXJlYWRpZXMtb2RhY3RyYS1sYXVuY2gtYWZ0ZXItbWVyY2stZXhpdC81MDMyMDcv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Bristol-Myers, Pfizer continue to build case for Eliquis",2017-08-28 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZWxpcXVpcy1lbWFuYXRlLWJyaXN0b2wtbXllcnMtcGZpemVyLWNhcmRpb3ZlcnNpb24tYWZpYi81MDM2NzMv0gEA?hl=en-US&gl=US&ceid=US%3Aen
J&J deal gives Cerecor much-needed cash infusion,2017-08-16 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2VyZWNvci1jZW8tcmV0aXJlLWpvaG5zb24tam9obnNvbi1kZWFsLXNhbGUvNDQ5NDY1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Novo's Victoza approved for CV benefit,2017-08-28 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92by12aWN0b3phLWNhcmRpb3Zhc2N1bGFyLWFwcHJvdmFsLWRpYWJldGVzLzUwMzY4OC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Shire launches newest ADHD med Mydayis,2017-08-30 00:00:00,https://news.google.com/./articles/CBMiVGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2hpcmUtbXlkYXlpcy1hZGhkLXVzLWxhdW5jaC1uZXJ1b3NjaWVuY2UvNTAzODgwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"CVS Health removes 17 drugs from formulary, adds outcomes ...",2017-08-02 00:00:00,https://news.google.com/./articles/CBMiZmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY3ZzLWhlYWx0aC0yMDE4LWZvcm11bGFyeS1leGNsdWRlLTE3LWRydWdzLW91dGNvbWVzLXByb2dyYW0vNDQ4NDUzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Location-based marketing drives real-time, real-world engagement ...",2017-08-29 00:00:00,https://news.google.com/./articles/CBMidmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL3Nwb25zL2xvY2F0aW9uLWJhc2VkLW1hcmtldGluZy1kcml2ZXMtcmVhbC10aW1lLXJlYWwtd29ybGQtZW5nYWdlbWVudC13aXRoLWhlYWx0LzUwMzQzOS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Vertex wins new Kalydeco approval, ups sales forecast",2017-08-01 00:00:00,https://news.google.com/./articles/CBMiVmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdmVydGV4LWthbHlkZWNvLWZkYS1hcHByb3ZhbC1ndWlkYW5jZS1yYWlzZS80NDgzNDEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Alnylam pauses clinical trials of hemophilia drug after patient death,2017-09-07 00:00:00,https://news.google.com/./articles/CBMicGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWxueWxhbS1wYXVzZXMtY2xpbmljYWwtdHJpYWxzLW9mLWhlbW9waGlsaWEtZHJ1Zy1hZnRlci1wYXRpZW50LWRlYXRoLzUwNDQ2Ny_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Teva fills top spot with Lundbeck CEO,2017-09-11 00:00:00,https://news.google.com/./articles/CBMiUGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdGV2YS1maWxscy10b3Atc3BvdC13aXRoLWx1bmRiZWNrLWNlby81MDQ2OTAv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Acer jumps on 7-year-old data,2017-09-25 00:00:00,https://news.google.com/./articles/CBMiTWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvQWNlci1zdG9jay1jZWxpcHJvbG9sLUVkc2l2by1zdHVkeS81MDU3NjQv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Smaller sales forces get the job done in rare disease,2017-09-18 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc21hbGxlci1zYWxlcy1mb3JjZXMtZ2V0LXRoZS1qb2ItZG9uZS1pbi1yYXJlLWRpc2Vhc2UvNTA0ODA5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Pfizer's Mylotarg gets a second shot at market,2017-09-01 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGZpemVycy1teWxvdGFyZy1nZXRzLWEtc2Vjb25kLXNob3QtYXQtbWFya2V0LzUwNDEwOC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Samsung Bioepis first to secure EMA backing for Herceptin biosimilar,2017-09-15 00:00:00,https://news.google.com/./articles/CBMiYWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2Ftc3VuZy1iaW9lcGlzLWZpcnN0LWVtYS1iYWNraW5nLWhlcmNlcHRpbi1iaW9zaW1pbGFyLzUwNTA1Mi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Industry Pulse: 10 charts on M&A, I/O and biosimilar threats",2017-09-01 00:00:00,https://news.google.com/./articles/CBMiY2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaW5kdXN0cnktcHVsc2UtMTAtY2hhcnRzLW9uLW1hLWlvLWFuZC1iaW9zaW1pbGFyLXRocmVhdHMvNTA0MTE1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
FDA warns drugmaker over misleading marketing of opioid,2017-09-06 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLXdhcm5pbmctbGV0dGVyLW9waW9pZC1jaXBoZXItcGhhcm1hLW1pc2JyYW5kaW5nLzUwNDM3My_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Premium price for Novartis' CAR-T sparks pushback from top PBM,2017-09-25 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2FyLXQtcHJpY2Uta3ltcmlhaC1leHByZXNzLXNjcmlwdHMtbmV3LXBheW1lbnQtbW9kZWwvNTA1NzMyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Lilly's abema gets FDA OK, setting it up for blockbuster status",2017-09-29 00:00:00,https://news.google.com/./articles/CBMiaGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbGlsbHlzLWFiZW1hLWdldHMtZmRhLW9rLXNldHRpbmctaXQtdXAtZm9yLWJsb2NrYnVzdGVyLXN0YXR1cy81MDYxNDEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"AbbVie, Amgen reach a deal on Humira biosimilar",2017-09-28 00:00:00,https://news.google.com/./articles/CBMiWWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWJidmllLWFtZ2VuLXJlYWNoLWEtZGVhbC1vbi1odW1pcmEtYmlvc2ltaWxhci81MDYwNDEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Amgen, Allergan win first approval of cancer biosimilar in US",2017-09-14 00:00:00,https://news.google.com/./articles/CBMiZGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW1nZW4tYmlvc2ltaWxhci1hdmFzdGluLXdpbi1mZGEtYXBwcm92YWwtZmlyc3QtY2FuY2VyLXVzLzUwNDk5MC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
5 Trends shaping the pharma sales force,2017-09-18 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc3BvdGxpZ2h0LXRyZW5kcy1waGFybWEtc2FsZXMtZm9yY2UtZGlnaXRhbC1tYXJrZXRpbmcvNTA0OTQ5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
What you need to know: The evolving pharma sales force,2017-09-26 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvd2hhdC15b3UtbmVlZC10by1rbm93LXRoZS1ldm9sdmluZy1waGFybWEtc2FsZXMtZm9yY2UvNTA1NzMxL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Novo Nordisk settles claims related to Victoza marketing,2017-09-06 00:00:00,https://news.google.com/./articles/CBMiY2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92by1ub3JkaXNrLXNldHRsZXMtY2xhaW1zLXJlbGF0ZWQtdG8tdmljdG96YS1tYXJrZXRpbmcvNTA0MzQwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Mallinckrodt tumbles after judge invalidates Inomax patents,2017-09-06 00:00:00,https://news.google.com/./articles/CBMiZmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWFsbGluY2tyb2R0LXR1bWJsZXMtYWZ0ZXItanVkZ2UtaW52YWxpZGF0ZXMtaW5vbWF4LXBhdGVudHMvNTA0Mzc2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
FDA targets illegal online pharmacies as part of global crackdown,2017-09-27 00:00:00,https://news.google.com/./articles/CBMibGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLXRhcmdldHMtaWxsZWdhbC1vbmxpbmUtcGhhcm1hY2llcy1hcy1wYXJ0LW9mLWdsb2JhbC1jcmFja2Rvd24vNTA1OTQwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Vertex grows CF franchise as combos move forward,2017-10-26 00:00:00,https://news.google.com/./articles/CBMiaWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdmVydGV4LWJvb3N0cy1zYWxlcy1mb3JlY2FzdHMtY3lzdGljLWZpYnJvc2lzLWRydWdzLW91dHBlcmZvcm0vNTA4MjI3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Generon moving ahead with Phase 3 trial following SPA,2017-10-11 00:00:00,https://news.google.com/./articles/CBMiSmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZ2VuZXJvbi1mZGEtcGhhc2UtMy1zcGEtYmluZXV0YS81MDcwNDMv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Amgen digs deeper in I/O with CytomX deal,2017-10-04 00:00:00,https://news.google.com/./articles/CBMiTGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW1nZW4tY3l0b214LWRlYWwtaW1tdW5vLW9uY29sb2d5LzUwNjQ2Ny_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Ignyta lifts off on cancer drug's best-in-class potential,2017-10-18 00:00:00,https://news.google.com/./articles/CBMiTmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaWdueXRhLWVudHJlY3RpbmliLWRhdGEtbHVuZy1jYW5jZXIvNTA3NTgzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Teva hit with surprise Copaxone generic, Mylan celebrates",2017-10-04 00:00:00,https://news.google.com/./articles/CBMiT2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdGV2YS1teWxhbi1jb3BheG9uZS1nZW5lcmljLWFwcHJvdmFsLzUwNjQ2My_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Lonza snatches Shire facility as biologics manufacturing rakes in ...,2017-10-05 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2hpcmUtbG9uemEtbWFudWZhY3R1cmluZy1mYWNpbGl0eS1kZWFsLW1hbW1hbGlhbi81MDY2MTIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Lilly's plans for abemaciclib dented by lung trial miss,2017-10-10 00:00:00,https://news.google.com/./articles/CBMiX2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZWxpLWxpbGx5LWFiZW1hY2ljbGliLWx1bmctY2FuY2VyLWZhaWx1cmUtdHJpYWwtbWlzcy81MDY5MDMv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Mixed results in NASH for Gilead,2017-10-25 00:00:00,https://news.google.com/./articles/CBMiS2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWl4ZWQtcmVzdWx0cy1pbi1uYXNoLWZvci1naWxlYWQvNTA4MTAyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Expanded label opens new market for Alexion's Soliris,2017-10-24 00:00:00,https://news.google.com/./articles/CBMiWWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWxleGlvbi1zb2xpcmlzLW15YXN0aGVuaWEtZ3JhdmlzLWZkYS1hcHByb3ZhbC81MDgwNzEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Lupin expands US presence with $150M Symbiomix deal,2017-10-11 00:00:00,https://news.google.com/./articles/CBMiU2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbHVwaW4tc3ltYmlvbWl4LWV4cGFuZHMtdXMtYnVzaW5lc3MtZGVhbC81MDcwMjYv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Flexion secures US approval for osteoarthritis drug,2017-10-09 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmxleGlvbi1vc3Rlb2FydGhyaXRpcy1GREEtYXBwcm92YWwtemlscmV0dGEvNTA2ODEwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"With Advair copies looming, GSK keeps focus on new drugs",2017-10-25 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvd2l0aC1hZHZhaXItY29waWVzLWxvb21pbmctZ3NrLWtlZXBzLWZvY3VzLW9uLW5ldy1kcnVncy81MDgxMTYv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Anthem leaves Express Scripts behind to roll out its own PBM,2017-10-18 00:00:00,https://news.google.com/./articles/CBMiSWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW50aGVtLXBibS1leHByZXNzLXNjcmlwdHMtY3ZzLzUwNzYwMS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Long rundowns of side effects can make drugs seem less risky ...,2017-10-11 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGhhcm1hY2V1dGljYWwtYWR2ZXJ0aXNpbmctc2lkZS1lZmZlY3RzLXJpc2t5LW1hcmtldGluZy81MDcwNTYv0gEA?hl=en-US&gl=US&ceid=US%3Aen
US Spinraza sales cause concern among Biogen investors,2017-10-24 00:00:00,https://news.google.com/./articles/CBMiYWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdXMtc3BpbnJhemEtc2FsZXMtY2F1c2UtY29uY2Vybi1hbW9uZy1iaW9nZW4taW52ZXN0b3JzLzUwNzk5NC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Merck slashes sales staff in cost-cutting exercise,2017-10-23 00:00:00,https://news.google.com/./articles/CBMiXWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWVyY2stc2xhc2hlcy1zYWxlcy1zdGFmZi1pbi1jb3N0LWN1dHRpbmctZXhlcmNpc2UvNTA3ODY5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Express Scripts: Specialty meds driving up US drug spend,2017-10-02 00:00:00,https://news.google.com/./articles/CBMiO2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZXhwcmVzcy1zY3JpcHRzLS81MDYyOTAv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Trevena cuts workforce 30% to free up cash,2017-10-13 00:00:00,https://news.google.com/./articles/CBMiVGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdHJldmVuYS1jdXRzLXdvcmtmb3JjZS0zMC10by1mcmVlLXVwLWNhc2gvNTA3MjYxL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Merck sales slip, even as Keytruda gains ground",2017-10-27 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWVyY2sta2V5dHJ1ZGEtc2FsZXMtbHVuZy1jYW5jZXItdGhpcmQtcXVhcnRlci1lYXJuaW5ncy81MDgzNTAv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Biosimilars could save US $150B over next decade,2017-10-24 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmlvc2ltaWxhcnMtY291bGQtc2F2ZS11cy0xNTBiLW92ZXItbmV4dC1kZWNhZGUvNTA3OTgyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Dynacure secures rights to Ionis rare disease drug,2017-11-10 00:00:00,https://news.google.com/./articles/CBMiXWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZHluYWN1cmUtc2VjdXJlcy1yaWdodHMtdG8taW9uaXMtcmFyZS1kaXNlYXNlLWRydWcvNTEwNjAwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Anthem reverses course, agrees to cover Sarepta's Duchenne drug",2017-11-13 00:00:00,https://news.google.com/./articles/CBMiaGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW50aGVtLXJldmVyc2VzLWNvdXJzZS1hZ3JlZXMtdG8tY292ZXItc2FyZXB0YXMtZHVjaGVubmUtZHJ1Zy81MTA3NDMv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Concordia faces fine for bad pricing behavior,2017-11-22 00:00:00,https://news.google.com/./articles/CBMiVmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY29uY29yZGlhLXVrLWNtYS1wcmljZS1nb3VnaW5nLXRoeXJvaWQtZHJ1Zy81MTE1NjAv0gEA?hl=en-US&gl=US&ceid=US%3Aen
The globalization of the pharma industry,2017-11-01 00:00:00,https://news.google.com/./articles/CBMiU2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdGhlLWdsb2JhbGl6YXRpb24tb2YtdGhlLXBoYXJtYS1pbmR1c3RyeS81MDk3OTIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Novartis sets Cosentyx hopes higher,2017-11-15 00:00:00,https://news.google.com/./articles/CBMiUmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92YXJ0aXMtY29zZW50eXgtZ3Jvd3RoLWltbXVub2xvZ3ktdG5mLzUxMTAxMy_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Viagra comes out from behind the counter in the UK,2017-11-29 00:00:00,https://news.google.com/./articles/CBMiVmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGZpemVyLXZpYWdyYS1vdGMtcGhhcm1hY3ktVUstZmlyc3QtY291bnRyeS81MTE4OTEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
AstraZeneca wins US approval for asthma biologic,2017-11-15 00:00:00,https://news.google.com/./articles/CBMiZGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYXN0cmF6ZW5lY2Etd2lucy1mZGEtYXBwcm92YWwtZmFzZW5yYS1iZW5yYWxpenVtYWItYXN0aG1hLzUxMDk5MS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Alecensa vs. Xalkori: New approval pits Roche against Pfizer,2017-11-08 00:00:00,https://news.google.com/./articles/CBMiZmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvcm9jaGUtYWxlY2Vuc2Etd2luLVVTLWFwcHJvdmFsLWZpcnN0LWxpbmUtdHJlYXRtZW50LXhhbGtvcmkvNTEwNDAyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Pfizer bolsters Eucrisa launch with two DTC campaigns,2018-09-03 00:00:00,https://news.google.com/./articles/CBMiaGh0dHBzOi8vd3d3Lm1tbS1vbmxpbmUuY29tL2hvbWUvY2hhbm5lbC9jYW1wYWlnbnMvcGZpemVyLWJvbHN0ZXJzLWV1Y3Jpc2EtbGF1bmNoLXdpdGgtdHdvLWR0Yy1jYW1wYWlnbnMv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Prescribed Reading: FDA approval spree, tax reform, deals pick up",2017-12-22 00:00:00,https://news.google.com/./articles/CBMiaWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcHJlc2NyaWJlZC1yZWFkaW5nLWZkYS1hcHByb3ZhbC1zcHJlZS10YXgtcmVmb3JtLWRlYWxzLXBpY2stdXAvNTEzNzIwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Biogen inks outcomes-based contract for MS meds,2017-12-06 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmlvZ2VuLW91dGNvbWVzLWJhc2VkLWNvbnRyYWN0LXByaW1lLW11bHRpcGxlLXNjbGVyb3Npcy81MTI0MjIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Ra shares tank on Soliris comparison,2017-12-05 00:00:00,https://news.google.com/./articles/CBMiT2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcmEtc2hhcmVzLXRhbmstb24tc29saXJpcy1jb21wYXJpc29uLzUxMjI2My_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Allergan picks up Repros to boost women's health offerings,2017-12-12 00:00:00,https://news.google.com/./articles/CBMiZGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWxsZXJnYW4tcGlja3MtdXAtcmVwcm9zLXRvLWJvb3N0LXdvbWVucy1oZWFsdGgtb2ZmZXJpbmdzLzUxMjg1Mi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Kymriah, Yescarta could be cost-effective, ICER finds",2017-12-21 00:00:00,https://news.google.com/./articles/CBMiYWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaWNlci1kcmFmdC1jYXItdC1jb3N0LWVmZmVjdGl2ZS1reW1yaWFoLXllc2NhcnRhLXByaWNlLzUxMzYyNS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Most Impressive Drug Launch: Roche's Ocrevus,2017-12-04 00:00:00,https://news.google.com/./articles/CBMiWWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbW9zdC1pbXByZXNzaXZlLWRydWctbGF1bmNoLXJvY2hlLW9jcmV2dXMtMjAxNy81MTA4MTQv0gEA?hl=en-US&gl=US&ceid=US%3Aen
FDA drops boxed warning for combo asthma drugs,2017-12-22 00:00:00,https://news.google.com/./articles/CBMiVmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLXJlbW92ZS1ib3hlZC13YXJuaW5nLWNvbWJvLWFzdGhtYS1kcnVncy81MTM3MTEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
JPM18: Alnylam and Sanofi reshuffle rare disease RNAi deal,2018-01-09 00:00:00,https://news.google.com/./articles/CBMiZGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvanBtMTgtYWxueWxhbS1hbmQtc2Fub2ZpLXJlc2h1ZmZsZS1yYXJlLWRpc2Vhc2Utcm5haS1kZWFsLzUxNDM2NS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Celgene buys Juno for $9B, deepening bet on CAR-T",2018-01-22 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2VsZ2VuZS1idXlzLWp1bm8tOS1iaWxsaW9uLWRlZXBlbmluZy1iZXQtY2FyLXQvNTE1MjI2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Novartis predicts growth pick-up on back of Cosentyx, Entresto",2018-01-24 00:00:00,https://news.google.com/./articles/CBMiaGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92YXJ0aXMtcHJlZGljdHMtZ3Jvd3RoLXBpY2stdXAtb24tYmFjay1vZi1jb3NlbnR5eC1lbnRyZXN0by81MTU0NDMv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Price for Spark gene therapy too high, ICER says",2018-01-16 00:00:00,https://news.google.com/./articles/CBMiZWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaWNlci1maW5kcy1zcGFyay1sdXh0dXJuYS1nZW5lLXRoZXJhcHktdG9vLWV4cGVuc2l2ZS1wcmljZS81MTQ4MjEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Allergan to cut 1000 jobs as generic competition threatens,2018-01-03 00:00:00,https://news.google.com/./articles/CBMiZWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWxsZXJnYW4tdG8tY3V0LTEwMDAtam9icy1hcy1nZW5lcmljLWNvbXBldGl0aW9uLXRocmVhdGVucy81MTM5OTEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Spark sets precedent with outcomes models, $850K gene therapy ...",2018-01-03 00:00:00,https://news.google.com/./articles/CBMicGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc3Bhcmstc2V0cy1wcmVjZWRlbnQtd2l0aC1vdXRjb21lcy1tb2RlbHMtODUway1nZW5lLXRoZXJhcHktcHJpY2UtdGFnLzUxMzk5Mi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
FDA to speed public notification of product recalls,2018-01-19 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLXRvLXNwZWVkLXB1YmxpYy1ub3RpZmljYXRpb24tb2YtcHJvZHVjdC1yZWNhbGxzLzUxNTE1NS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Oral form of Novo's Ozempic hits primary endpoint in first Phase 3,2018-02-23 00:00:00,https://news.google.com/./articles/CBMibGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvb3JhbC1mb3JtLW9mLW5vdm9zLW96ZW1waWMtaGl0cy1wcmltYXJ5LWVuZHBvaW50LWluLWZpcnN0LXBoYXNlLTMvNTE3NzEwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Teva's Copaxone sales hit hastened with OK of Novartis copy,2018-02-13 00:00:00,https://news.google.com/./articles/CBMiZWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdGV2YXMtY29wYXhvbmUtc2FsZXMtaGl0LWhhc3RlbmVkLXdpdGgtb2stb2Ytbm92YXJ0aXMtY29weS81MTY5Njkv0gEA?hl=en-US&gl=US&ceid=US%3Aen
What Gilead taught pharma about pricing a cure,2018-02-12 00:00:00,https://news.google.com/./articles/CBMiWWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvd2hhdC1naWxlYWQtdGF1Z2h0LXBoYXJtYS1hYm91dC1wcmljaW5nLWEtY3VyZS81MTY5MDYv0gEA?hl=en-US&gl=US&ceid=US%3Aen
FDA adds black box warning to Intercept's Ocaliva,2018-02-01 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLWFkZHMtYmxhY2stYm94LXdhcm5pbmctdG8taW50ZXJjZXB0cy1vY2FsaXZhLzUxNjExNS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Express Scripts joins Walgreens Boots to cut biosimilar costs,2018-02-21 00:00:00,https://news.google.com/./articles/CBMiaGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZXhwcmVzcy1zY3JpcHRzLWpvaW5zLXdhbGdyZWVucy1ib290cy10by1jdXQtYmlvc2ltaWxhci1jb3N0cy81MTc1MzEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
BIO: Pain pipeline lacking as opioid crisis continues,2018-02-14 00:00:00,https://news.google.com/./articles/CBMiX2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmlvLXBhaW4tcGlwZWxpbmUtbGFja2luZy1hcy1vcGlvaWQtY3Jpc2lzLWNvbnRpbnVlcy81MTcwNjYv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Spark lays groundwork for US Luxturna launch,2018-02-21 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc3BhcmstbGF5cy1ncm91bmR3b3JrLWZvci11cy1sdXh0dXJuYS1sYXVuY2gvNTE3NTUwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Rubraca struggling from behind in PARP market,2018-02-27 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcnVicmFjYS1zdHJ1Z2dsaW5nLWZyb20tYmVoaW5kLWluLXBhcnAtbWFya2V0LzUxNzk5NS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Allergan picks up pneumonia indication for Avycaz,2018-02-02 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWxsZXJnYW4tcGlja3MtdXAtcG5ldW1vbmlhLWluZGljYXRpb24tZm9yLWF2eWNhei81MTYxODkv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Opioid antagonists vs. agonists: A battle to fight addiction,2018-03-26 00:00:00,https://news.google.com/./articles/CBMiZ2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc3BvdGxpZ2h0LXBhaW4tb3Bpb2lkLWFkZGljdGlvbi10cmVhdG1lbnRzLXZpdml0cm9sLW5hbG94b25lLzUxOTU1MS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Indivior loses patent battle for Suboxone Film,2018-03-23 00:00:00,https://news.google.com/./articles/CBMiWWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaW5kaXZpb3ItbG9zZXMtcGF0ZW50LWJhdHRsZS1mb3Itc3Vib3hvbmUtZmlsbS81MTk4Njgv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Amgen taps Omnicom's Hearts & Science for media job,2018-03-23 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW1nZW4tdGFwcy1vbW5pY29tcy1oZWFydHMtc2NpZW5jZS1mb3ItbWVkaWEtam9iLzUxOTg0Ny_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Roche's Hemlibra to be biggest blockbuster of next 5 years, report ...",2018-03-22 00:00:00,https://news.google.com/./articles/CBMiamh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvcm9jaGUtaGVtbGlicmEtYmxvY2tidXN0ZXItcmVwb3J0LUJpa3RhcnZ5LWRpYWJldGVzLWdpbGVhZC1ub3ZvLzUxOTc0Ny_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Mundipharma inks third biosimilar deal with Celltrion,2018-03-20 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbXVuZGlwaGFybWEtaW5rcy10aGlyZC1iaW9zaW1pbGFyLWRlYWwtd2l0aC1jZWxsdHJpb24vNTE5NTgwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Aetna to offer point of sale pharmacy rebates to 3M customers,2018-03-27 00:00:00,https://news.google.com/./articles/CBMiaGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWV0bmEtdG8tb2ZmZXItcG9pbnQtb2Ytc2FsZS1waGFybWFjeS1yZWJhdGVzLXRvLTNtLWN1c3RvbWVycy81MjAwNjcv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Sanofi aims to lower copay costs with higher-capacity Toujeo pen,2018-03-28 00:00:00,https://news.google.com/./articles/CBMia2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2Fub2ZpLWFpbXMtdG8tbG93ZXItY29wYXktY29zdHMtd2l0aC1oaWdoZXItY2FwYWNpdHktdG91amVvLXBlbi81MjAxOTAv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Alnylam, Dicerna settle RNAi trade secrets lawsuit",2018-04-21 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWxueWxhbS1kaWNlcm5hLXNldHRsZS1ybmFpLXRyYWRlLXNlY3JldHMtbGF3c3VpdC81MjE4ODgv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Redx study on hold before getting off the ground,2018-04-02 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcmVkeC1zdHVkeS1vbi1ob2xkLWJlZm9yZS1nZXR0aW5nLW9mZi10aGUtZ3JvdW5kLzUyMDM2NS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
J&J unfazed by falling Remicade sales,2018-04-17 00:00:00,https://news.google.com/./articles/CBMiT2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvamotdW5mYXplZC1ieS1mYWxsaW5nLXJlbWljYWRlLXNhbGVzLzUyMTUxNC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Pfizer's Epogen biosimilar finally gets FDA go-ahead,2018-05-16 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGZpemVycy1lcG9nZW4tYmlvc2ltaWxhci1maW5hbGx5LWdldHMtZmRhLWdvLWFoZWFkLzUyMzYzNy_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Post split talk, Ironwood fights off Denner addition to board",2018-05-01 00:00:00,https://news.google.com/./articles/CBMiXWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaXJvbndvb2QtY2F2ZXMtdG8tYWN0aXZpc3QtcHJlc3N1cmUtc3BsaXRzLWNvbXBhbnkvNTIyNTQ3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
AstraZeneca finally gets US Lokelma approval,2018-05-21 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYXN0cmF6ZW5lY2EtZmluYWxseS1nZXRzLXVzLWxva2VsbWEtYXBwcm92YWwvNTIzOTM1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Another lucky escape for Roche as Novartis receives CRL for ...,2018-05-04 00:00:00,https://news.google.com/./articles/CBMidmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW5vdGhlci1sdWNreS1lc2NhcGUtZm9yLXJvY2hlLWFzLW5vdmFydGlzLXJlY2VpdmVzLWNybC1mb3Itcml0dXhhbi1iaW9zaW1pLzUyMjgyNy_SAQA?hl=en-US&gl=US&ceid=US%3Aen
FDA approves first TPO agonist for chronic liver disease,2018-05-22 00:00:00,https://news.google.com/./articles/CBMiY2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLWFwcHJvdmVzLWZpcnN0LXRwby1hZ29uaXN0LWZvci1jaHJvbmljLWxpdmVyLWRpc2Vhc2UvNTI0MDUzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
CMS weighing National Coverage Decision for CAR-T,2018-05-17 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY21zLWNhci10LW5hdGlvbmFsLWNvdmVyYWdlLWRlY2lzaW9uLWt5bXJpYWgteWVzY2FydGEvNTIzNzc3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Roche buys out Foundation Med in $2.4B bet on targeted cancer ...,2018-06-19 00:00:00,https://news.google.com/./articles/CBMicGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvcm9jaGUtYnV5cy1vdXQtZm91bmRhdGlvbi1tZWQtaW4tMjRiLWJldC1vbi10YXJnZXRlZC1jYW5jZXItdHJlYXRtZW50LzUyNjAyOS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Purdue Pharma lays off 350, cutting remainder of sales force",2018-06-20 00:00:00,https://news.google.com/./articles/CBMiZmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcHVyZHVlLXBoYXJtYS1sYXlzLW9mZi0zNTAtY3V0dGluZy1yZW1haW5kZXItb2Ytc2FsZXMtZm9yY2UvNTI2MTYxL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Dova reveals $9K to $13.5K Doptelet price, stock sags",2018-06-01 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZG92YS1yZXZlYWxzLTlrLXRvLTEzNWstZG9wdGVsZXQtcHJpY2Utc3RvY2stc2Fncy81MjQ3NjAv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Achaogen gets a yes and a no for antibiotic Zemdri,2018-06-27 00:00:00,https://news.google.com/./articles/CBMiXWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWNoYW9nZW4tZ2V0cy1hLXllcy1hbmQtYS1uby1mb3ItYW50aWJpb3RpYy16ZW1kcmkvNTI2NjQ3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
CMS to states: Medicaid must cover accelerated approval drugs,2018-06-28 00:00:00,https://news.google.com/./articles/CBMiZ2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY21zLXRvLXN0YXRlcy1tZWRpY2FpZC1tdXN0LWNvdmVyLWFjY2VsZXJhdGVkLWFwcHJvdmFsLWRydWdzLzUyNjc2Ny_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Pfizer rejiggers business units,2018-07-11 00:00:00,https://news.google.com/./articles/CBMiSmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGZpemVyLXJlamlnZ2Vycy1idXNpbmVzcy11bml0cy81Mjc1NDcv0gEA?hl=en-US&gl=US&ceid=US%3Aen
J&J taps German Merck to market Invokana in China,2018-07-13 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvamotdGFwcy1nZXJtYW4tbWVyY2stdG8tbWFya2V0LWludm9rYW5hLWluLWNoaW5hLzUyNzcxOS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Cannabis-based drugs and devices: A winning combo?,2018-07-17 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2FubmFiaXMtYmFzZWQtZHJ1Z3MtYW5kLWRldmljZXMtYS13aW5uaW5nLWNvbWJvLzUyNzkzOS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"After failure, Zynerba shifts gears to save cash",2018-07-05 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWZ0ZXItZmFpbHVyZS16eW5lcmJhLXNoaWZ0cy1nZWFycy10by1zYXZlLWNhc2gvNTI3MTQ4L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Mesoblast gets access to China through deal with Tasly,2018-07-18 00:00:00,https://news.google.com/./articles/CBMiYWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWVzb2JsYXN0LWdldHMtYWNjZXNzLXRvLWNoaW5hLXRocm91Z2gtZGVhbC13aXRoLXRhc2x5LzUyODAzMy_SAQA?hl=en-US&gl=US&ceid=US%3Aen
FDA calls Pfizer Estring marketing misleading,2018-07-03 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLWNhbGxzLXBmaXplci1lc3RyaW5nLW1hcmtldGluZy1taXNsZWFkaW5nLzUyNzAyNi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Kyowa Hakko picks up warning letter from the FDA,2018-08-29 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mva3lvd2EtaGFra28tcGlja3MtdXAtd2FybmluZy1sZXR0ZXItZnJvbS10aGUtZmRhLzUzMTIyNC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Mallinckrodt gets CRL for newborn jaundice drug,2018-08-23 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWFsbGluY2tyb2R0LWZkYS1jcmwtZm9yLW5ld2Jvcm4tamF1bmRpY2Utc3Rhbm5zb3BvcmZpbi81MzA3NzIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"GSK will close manufacturing plant in Ireland, cutting 165 jobs",2018-08-21 00:00:00,https://news.google.com/./articles/CBMiaWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZ3NrLXdpbGwtY2xvc2UtbWFudWZhY3R1cmluZy1wbGFudC1pbi1pcmVsYW5kLWN1dHRpbmctMTY1LWpvYnMvNTMwNTY1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Pfizer inks marketing deal for Exact's Cologuard,2018-08-22 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGZpemVyLWV4YWN0LW1hcmtldGluZy1kZWFsLWNhbmNlci1zY3JlZW5lci1jb2xvZ3VhcmQvNTMwNjg0L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
FDA sends Apotex warning letter for Indian manufacturing violations,2018-08-16 00:00:00,https://news.google.com/./articles/CBMicGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLXNlbmRzLWFwb3RleC13YXJuaW5nLWxldHRlci1mb3ItaW5kaWFuLW1hbnVmYWN0dXJpbmctdmlvbGF0aW9ucy0xLzUzMDI4Ny_SAQA?hl=en-US&gl=US&ceid=US%3Aen
CVS adopts ICER metrics in shift to value-based drug pricing,2018-08-15 00:00:00,https://news.google.com/./articles/CBMiZ2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY3ZzLWFkb3B0cy1pY2VyLW1ldHJpY3MtaW4tc2hpZnQtdG8tdmFsdWUtYmFzZWQtZHJ1Zy1wcmljaW5nLzUzMDE4MS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Perrigo to split off generic drugs unit,2018-08-10 00:00:00,https://news.google.com/./articles/CBMiUmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGVycmlnby10by1zcGxpdC1vZmYtZ2VuZXJpYy1kcnVncy11bml0LzUyOTgxNC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Acorda gets reprieve as Ampyra generic is delayed,2018-08-06 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWNvcmRhLWdldHMtcmVwcmlldmUtYXMtYW1weXJhLWdlbmVyaWMtaXMtZGVsYXllZC81Mjk0MTgv0gEA?hl=en-US&gl=US&ceid=US%3Aen
FDA OKs first generic under new approval pathway,2018-08-08 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLW9rcy1maXJzdC1nZW5lcmljLXVuZGVyLW5ldy1hcHByb3ZhbC1wYXRod2F5LzUyOTY5My_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Drug combos may prove more costly than generic components ...,2018-08-22 00:00:00,https://news.google.com/./articles/CBMicGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZHJ1Zy1jb21ib3MtbWF5LXByb3ZlLW1vcmUtY29zdGx5LXRoYW4tZ2VuZXJpYy1jb21wb25lbnRzLXN0dWR5LWZpbmRzLzUzMDY2My_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Alnylam's Onpattro cleared in Europe as ICER sets pricing battle,2018-08-30 00:00:00,https://news.google.com/./articles/CBMiamh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWxueWxhbXMtb25wYXR0cm8tY2xlYXJlZC1pbi1ldXJvcGUtYXMtaWNlci1zZXRzLXByaWNpbmctYmF0dGxlLzUzMTMxNS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Harvard Pilgrim offers rare peek at 6 years of drug costs,2018-08-28 00:00:00,https://news.google.com/./articles/CBMiZGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaGFydmFyZC1waWxncmltLW9mZmVycy1yYXJlLXBlZWstYXQtNi15ZWFycy1vZi1kcnVnLWNvc3RzLzUzMTEwNS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"ICER update gives boost to Tremfya, risankizumab for psoriasis",2018-08-06 00:00:00,https://news.google.com/./articles/CBMiaGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaWNlci11cGRhdGUtZ2l2ZXMtYm9vc3QtdG8tdHJlbWZ5YS1yaXNhbmtpenVtYWItZm9yLXBzb3JpYXNpcy81Mjk0MjAv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Sun Pharma receives FDA approval for dry eye drug,2018-08-16 00:00:00,https://news.google.com/./articles/CBMiT2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc3VuLXBoYXJtYS1mZGEtYXBwcm92YWwtZHJ5LWV5ZS1kcnVnLzUzMDI2NC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
FDA warns of link between some diabetes drugs and serious infection,2018-08-30 00:00:00,https://news.google.com/./articles/CBMibmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLXdhcm5zLW9mLWxpbmstYmV0d2Vlbi1zb21lLWRpYWJldGVzLWRydWdzLWFuZC1zZXJpb3VzLWluZmVjdGlvbi81MzEyOTIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Alexion to buy Syntimmune in potential $1.2B deal,2018-09-26 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWxleGlvbi10by1idXktc3ludGltbXVuZS1pbi1wb3RlbnRpYWwtMTJiLWRlYWwvNTMzMjgwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Clovis, execs pay up to settle charges of misleading investors",2018-09-19 00:00:00,https://news.google.com/./articles/CBMiaGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2xvdmlzLWV4ZWNzLXBheS11cC10by1zZXR0bGUtY2hhcmdlcy1vZi1taXNsZWFkaW5nLWludmVzdG9ycy81MzI3MjIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Pfizer showcases JAK pipeline with mid-stage results,2018-09-17 00:00:00,https://news.google.com/./articles/CBMiX2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGZpemVyLXNob3djYXNlcy1qYWstcGlwZWxpbmUtd2l0aC1taWQtc3RhZ2UtcmVzdWx0cy81MzI0Nzcv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Roche hits roadblock in UK over Ocrevus price,2018-09-10 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvcm9jaGUtaGl0cy1yb2FkYmxvY2staW4tdWstb3Zlci1vY3JldnVzLXByaWNlLzUzMTk0Ny_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Federal court rules Ampyra patents invalid, sinking Acorda stock",2018-09-10 00:00:00,https://news.google.com/./articles/CBMia2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmVkZXJhbC1jb3VydC1ydWxlcy1hbXB5cmEtcGF0ZW50cy1pbnZhbGlkLWFjb3JkYS1zdG9jay1zaW5rcy0yNS81MzE5NzEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Patient groups attack CVS use of ICER metrics, urge rethink",2018-09-14 00:00:00,https://news.google.com/./articles/CBMiZWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGF0aWVudC1ncm91cHMtYXR0YWNrLWN2cy11c2Utb2YtaWNlci1tZXRyaWNzLXVyZ2UtcmV0aGluay81MzIzODMv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Shionogi launches cheaper rival to Dova's Doptelet,2018-09-04 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2hpb25vZ2ktbGF1bmNoZXMtY2hlYXBlci1yaXZhbC10by1kb3Zhcy1kb3B0ZWxldC81MzE1MTYv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"PhRMA, hospital war over drug prices heats up",2018-09-06 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGhybWEtaG9zcGl0YWwtd2FyLW92ZXItZHJ1Zy1wcmljZXMtaGVhdHMtdXAvNTMxNzU2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
BlueCross BlueShield Tennessee drops Oxycontin in favor of ...,2018-09-07 00:00:00,https://news.google.com/./articles/CBMidWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmx1ZWNyb3NzLWJsdWVzaGllbGQtdGVubmVzc2VlLWRyb3BzLW94eWNvbnRpbi1pbi1mYXZvci1vZi1jb2xsZWdpdW1zLWNvbXAvNTMxODQ4L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Sanofi reaches $25M settlement with SEC on bribery charges,2018-09-05 00:00:00,https://news.google.com/./articles/CBMiUGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2Fub2ZpLXNldHRsZW1lbnQtc2VjLWJyaWJlcnktY2hhcmdlcy81MzE2MDAv0gEA?hl=en-US&gl=US&ceid=US%3Aen
UK High Court OKs Avastin off-label use in wet AMD,2018-09-24 00:00:00,https://news.google.com/./articles/CBMiXWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdWstaGlnaC1jb3VydC1va3MtYXZhc3Rpbi1vZmYtbGFiZWwtdXNlLWluLXdldC1hbWQvNTMzMDQ2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Amgen faces a bigger European challenge to Neulasta,2018-09-24 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW1nZW4tZmFjZXMtYS1iaWdnZXItZXVyb3BlYW4tY2hhbGxlbmdlLXRvLW5ldWxhc3RhLzUzMzA0NS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Attention deficit disorder focus turns to side effects,2018-09-20 00:00:00,https://news.google.com/./articles/CBMicGh0dHBzOi8vd3d3LmV2YWx1YXRlLmNvbS92YW50YWdlL2FydGljbGVzL2FuYWx5c2lzL3Nwb3RsaWdodC9hdHRlbnRpb24tZGVmaWNpdC1kaXNvcmRlci1mb2N1cy10dXJucy1zaWRlLWVmZmVjdHPSASZodHRwOi8vd3d3LmV2YWx1YXRlLmNvbS9ub2RlLzEzODI3L2FtcA?hl=en-US&gl=US&ceid=US%3Aen
J&J snaps up key label expansion for Xarelto,2018-10-15 00:00:00,https://news.google.com/./articles/CBMiZWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvam9obnNvbi14YXJlbHRvLWxhYmVsLWFwcHJvdmFsLW1ham9yLWNhcmRpb3Zhc2N1bGFyLWV2ZW50cy81Mzk2Njgv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Momenta to halve workforce with 110 job cuts, including co-founder ...",2018-10-02 00:00:00,https://news.google.com/./articles/CBMidGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbW9tZW50YS10by1oYWx2ZS13b3JrZm9yY2Utd2l0aC0xMTAtam9iLWN1dHMtaW5jbHVkaW5nLWNvLWZvdW5kZXItYW5kLWNmby81Mzg2NTcv0gEA?hl=en-US&gl=US&ceid=US%3Aen
First Amendment takes center stage in DTC price fight,2018-10-22 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZHRjLWRydWctcHJpY2UtZmlnaHQtZmlyc3QtYW1lbmRtZW50LXRha2VzLWNlbnRlci1zdGFnZS81Mzk0NzMv0gEA?hl=en-US&gl=US&ceid=US%3Aen
GSK opens new Ellipta plant in Scotland,2018-10-25 00:00:00,https://news.google.com/./articles/CBMiUmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZ3NrLW9wZW5zLW5ldy1lbGxpcHRhLXBsYW50LWluLXNjb3RsYW5kLzU0MDYwNi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
J&J's top-seller Stelara looks set to expand into ulcerative colitis,2018-10-09 00:00:00,https://news.google.com/./articles/CBMibWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvampzLXRvcC1zZWxsZXItc3RlbGFyYS1sb29rcy1zZXQtdG8tZXhwYW5kLWludG8tdWxjZXJhdGl2ZS1jb2xpdGlzLzUzOTIyOC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Mylan's generic Copaxone wins in court, but market barriers remain",2018-10-15 00:00:00,https://news.google.com/./articles/CBMia2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbXlsYW5zLWdlbmVyaWMtY29wYXhvbmUtd2lucy1pbi1jb3VydC1idXQtbWFya2V0LWJhcnJpZXJzLXJlbWFpbi81Mzk2NjYv0gEA?hl=en-US&gl=US&ceid=US%3Aen
AbbVie reaches 5th deal to secure Humira through 2023,2018-10-19 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWJidmllLXJlYWNoZXMtNXRoLWRlYWwtdG8tc2VjdXJlLWh1bWlyYS10aHJvdWdoLTIwMjMvNTQwMDk1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Roche's Kadcyla beats out Herceptin in Phase 3,2018-10-16 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvcm9jaGVzLWthZGN5bGEtYmVhdHMtb3V0LWhlcmNlcHRpbi1pbi1waGFzZS0zLzUzOTc3Ni_SAQA?hl=en-US&gl=US&ceid=US%3Aen
An early approval puts Pfizer's Talzenna in a crowded field,2018-10-17 00:00:00,https://news.google.com/./articles/CBMiZWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW4tZWFybHktYXBwcm92YWwtcHV0cy1wZml6ZXJzLXRhbHplbm5hLWluLWEtY3Jvd2RlZC1maWVsZC81Mzk4OTMv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Amgen launches TV spot for Aimovig in tight CGRP market,2018-10-17 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYW1nZW4tbGF1bmNoZXMtdHYtc3BvdC1mb3ItYWltb3ZpZy1pbi10aWdodC1jZ3JwLW1hcmtldC81Mzk5NDIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Sage depression drug to cost between $20K and $35K, if approved",2018-11-07 00:00:00,https://news.google.com/./articles/CBMiZ2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2FnZS1kZXByZXNzaW9uLWRydWctdG8tY29zdC1iZXR3ZWVuLTIway1hbmQtMzVrLWlmLWFwcHJvdmVkLzU0MTYxMy_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Insulin drugmakers under scrutiny for pricing, patent practices",2018-11-02 00:00:00,https://news.google.com/./articles/CBMiaWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaW5zdWxpbi1kcnVnbWFrZXJzLXVuZGVyLXNjcnV0aW55LWZvci1wcmljaW5nLXBhdGVudC1wcmFjdGljZXMvNTQxMjc1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Merck increased list prices on Keytruda, Gardasil in November",2018-11-29 00:00:00,https://news.google.com/./articles/CBMiZ2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWVyY2staW5jcmVhc2VkLWxpc3QtcHJpY2VzLW9uLWtleXRydWRhLWdhcmRhc2lsLWluLW5vdmVtYmVyLzU0MzI0MC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
ICER finalizes report finding asthma biologics too pricey,2018-11-15 00:00:00,https://news.google.com/./articles/CBMiU2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaWNlci1hc3RobWEtYmlvbG9naWNzLXByaWNlLWZpbmFsLXJlcG9ydC81NDIzNDIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Roche pulls EU application for Tecentriq in kidney cancer,2018-11-19 00:00:00,https://news.google.com/./articles/CBMiZGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvcm9jaGUtcHVsbHMtZXUtYXBwbGljYXRpb24tZm9yLXRlY2VudHJpcS1pbi1raWRuZXktY2FuY2VyLzU0MjU4NC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
UK calls Vertex on contentious Orkambi negotiations,2018-11-12 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdmVydGV4LW9ya2FtYmktdWstcHJpY2UtY2YtcmVpbWJ1cnNlbWVudC1sZXR0ZXIvNTQxOTk5L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Court opens path for Dr. Reddy's to launch generic Suboxone,2018-11-21 00:00:00,https://news.google.com/./articles/CBMiZGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY291cnQtb3BlbnMtcGF0aC1mb3ItZHItcmVkZHlzLXRvLWxhdW5jaC1nZW5lcmljLXN1Ym94b25lLzU0Mjc3NS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Kaleo under fire for price hikes on naloxone treatment,2018-11-19 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mva2FsZW8tcHJpY2UtaGlrZXMtbmFsb3hvbmUtc2VuYXRlLTYwLW1pbnV0ZXMvNTQyNTkyL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"California, Massachusetts go toe-to-toe for title of best biotech hub",2018-11-14 00:00:00,https://news.google.com/./articles/CBMib2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY2FsaWZvcm5pYS1tYXNzYWNodXNldHRzLWdvLXRvZS10by10b2UtZm9yLXRpdGxlLW9mLWJlc3QtYmlvdGVjaC1odWIvNTQyMDQ0L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Express Scripts plans 'Flex' formulary focused on authorized generics,2018-11-14 00:00:00,https://news.google.com/./articles/CBMiaGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZXhwcmVzcy1zY3JpcHRzLWZsZXgtZm9ybXVsYXJ5LWdpbGVhZC1hdXRob3JpemVkLWFsdGVybmF0aXZlcy81NDIyNTkv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Mylan, Theravance win FDA approval for COPD drug",2018-11-12 00:00:00,https://news.google.com/./articles/CBMiUWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbXlsYW4tdGhlcmF2YW5jZS15dWxwZXJpLWNvcGQtYXBwcm92YWwvNTQxOTk0L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Sanofi, Denali Launch $1B+ Alliance to Develop RIPK1 Inhibitors for ...",2018-11-01 00:00:00,https://news.google.com/./articles/CBMihAFodHRwczovL3d3dy5nZW5lbmduZXdzLmNvbS9uZXdzL3Nhbm9maS1kZW5hbGktbGF1bmNoLTFiLWFsbGlhbmNlLXRvLWRldmVsb3AtcmlwazEtaW5oaWJpdG9ycy1mb3ItbmV1cm9sb2dpY2FsLWluZmxhbW1hdG9yeS1kaXNlYXNlcy_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Pfizer to add 100 oncology R&D jobs, cut others amid restructure",2018-12-11 00:00:00,https://news.google.com/./articles/CBMiaWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGZpemVyLXRvLWFkZC0xMDAtb25jb2xvZ3ktcmQtam9icy1jdXQtb3RoZXJzLWFtaWQtcmVzdHJ1Y3R1cmUvNTQ0MTIwL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Novartis loses top exec as oncology head Barrett departs,2018-12-20 00:00:00,https://news.google.com/./articles/CBMiY2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92YXJ0aXMtbG9zZXMtdG9wLWV4ZWMtYXMtb25jb2xvZ3ktaGVhZC1iYXJyZXR0LWRlcGFydHMvNTQ0ODkzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Merck KGaA trades rights for equity in amended CAR-T pact,2018-12-21 00:00:00,https://news.google.com/./articles/CBMiUWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWVyY2sta2dhYS1jYXItdC1pbnRyZXhvbi1kZWFsLWFtZW5kZWQvNTQ0OTcxL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
J&J's Actelion pays out $360M to resolve kickback claims,2018-12-10 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvampzLWFjdGVsaW9uLXBheXMtb3V0LTM2MG0tdG8tcmVzb2x2ZS1raWNrYmFjay1jbGFpbXMvNTQzOTY1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Drug Launch of the Year: Amgen and Novartis' Aimovig,2018-12-03 00:00:00,https://news.google.com/./articles/CBMiWWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZGl2ZS1hd2FyZHMtZHJ1Zy1sYXVuY2gtYW1nZW4tbm92YXJ0aXMtYWltb3ZpZy81Mzk1OTMv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"FedEx, Walgreens partner for next-day delivery of prescription drugs",2018-12-07 00:00:00,https://news.google.com/./articles/CBMibWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvd2FsZ3JlZW5zLWZlZGV4LXBhcnRuZXJzaGlwLW5leHQtZGF5LWRlbGl2ZXJ5LXByZXNjcmlwdGlvbi1zZXJ2aWNlLzU0Mzk5Ny_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Walgreens pays $270M to settle Medicaid fraud allegations,2019-01-23 00:00:00,https://news.google.com/./articles/CBMiY2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvd2FsZ3JlZW5zLXBheXMtMjcwbS10by1zZXR0bGUtbWVkaWNhaWQtZnJhdWQtYWxsZWdhdGlvbnMvNTQ2NjM2L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Voyager vaults higher on Neurocrine deal for Parkinson's gene ...,2019-01-29 00:00:00,https://news.google.com/./articles/CBMib2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvdm95YWdlci12YXVsdHMtaGlnaGVyLW9uLW5ldXJvY3JpbmUtZGVhbC1mb3ItcGFya2luc29ucy1nZW5lLXRoZXJhcHkvNTQ3MTAxL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Gossamer set to bypass SEC with IPO as Nasdaq charts path for ...,2019-01-24 00:00:00,https://news.google.com/./articles/CBMib2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZ29zc2FtZXItc2V0LXRvLWJ5cGFzcy1zZWMtd2l0aC1pcG8tYXMtbmFzZGFxLWNoYXJ0cy1wYXRoLWZvci1vdGhlcnMvNTQ2NzU3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Pharma DTC spending outpaces rest of medical marketing, JAMA ...",2019-01-07 00:00:00,https://news.google.com/./articles/CBMicmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGhhcm1hLWR0Yy1zcGVuZGluZy1vdXRwYWNlcy1yZXN0LW9mLW1lZGljYWwtbWFya2V0aW5nLWphbWEtc3R1ZHktZmluZHMvNTQ1NDQxL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Bluebird proposes installment plan for LentiGlobin gene therapy,2019-01-09 00:00:00,https://news.google.com/./articles/CBMicGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvanBtMTktYmx1ZWJpcmQtcHJvcG9zZXMtaW5zdGFsbG1lbnQtcGxhbi1mb3ItbGVudGlnbG9iaW4tZ2VuZS10aGVyYXB5LzU0NTY0Ni_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"NICE turns down Novartis' Aimovig, flagging clinical trial concerns",2019-01-11 00:00:00,https://news.google.com/./articles/CBMibGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbmljZS10dXJucy1kb3duLW5vdmFydGlzLWFpbW92aWctZmxhZ2dpbmctY2xpbmljYWwtdHJpYWwtY29uY2VybnMvNTQ1ODUzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Esperion licenses European rights on cholesterol drug for $300M,2019-01-04 00:00:00,https://news.google.com/./articles/CBMiXmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZXNwZXJpb24tYmVtcGVkb2ljLWFjaWQtZGFpaWNoaS1saWNlbnNlLWNob2xlc3Rlcm9sLzU0NTIzNi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
When Will There Be a Cure for Lou Gehrig‚Äôs Disease?,2019-02-23 00:00:00,https://news.google.com/./articles/CBMiOmh0dHBzOi8vd3d3Lm5hbmFseXplLmNvbS8yMDE5LzAyL2N1cmUtbG91LWdlaHJpZ3MtZGlzZWFzZS_SAUBodHRwczovL3d3dy5uYW5hbHl6ZS5jb20vMjAxOS8wMi9jdXJlLWxvdS1nZWhyaWdzLWRpc2Vhc2UvP2FtcD0x?hl=en-US&gl=US&ceid=US%3Aen
"Lilly lowers 2019 revenue hopes, citing Lartruvo failure",2019-02-06 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbGlsbHktbG93ZXJzLTIwMTktZ3VpZGFuY2UtbGFydHJ1dm8tbG94by1yZXZlbnVlLzU0Nzc5OC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Dr. Reddy's relaunches Suboxone generic after court victories,2019-02-21 00:00:00,https://news.google.com/./articles/CBMiZmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZHItcmVkZHlzLXJlbGF1bmNoZXMtc3Vib3hvbmUtZ2VuZXJpYy1hZnRlci1jb3VydC12aWN0b3JpZXMvNTQ4OTA3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Mylan launches Advair generic at 70% discount,2019-02-13 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbXlsYW4tbGF1bmNoZXMtYWR2YWlyLWdlbmVyaWMtYXQtNzAtZGlzY291bnQvNTQ4MzQzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
FDA flags manufacturing shortcomings at Actavis plant,2019-03-07 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLWZsYWdzLW1hbnVmYWN0dXJpbmctc2hvcnRjb21pbmdzLWF0LWFjdGF2aXMtcGxhbnQvNTUwMDAxL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Thermo Fisher to buy Brammer Bio for $1.7B, expanding gene ...",2019-03-25 00:00:00,https://news.google.com/./articles/CBMiZGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdGhlcm1vLWZpc2hlci1icmFtbWVyLWJpby1nZW5lLXRoZXJhcHktbWFudWZhY3R1cmluZy1kZWFsLzU1MTIyNS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Novo, seeking edge in diabetes, posts positive Ozempic data",2019-03-05 00:00:00,https://news.google.com/./articles/CBMiZGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92by1zZWVraW5nLWVkZ2UtaW4tZGlhYmV0ZXMtcG9zdHMtcG9zaXRpdmUtb3plbXBpYy1kYXRhLzU0OTc3NC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"Lilly follows Gilead, Mylan lead with authorized generic play",2019-03-05 00:00:00,https://news.google.com/./articles/CBMiZ2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbGlsbHktZm9sbG93cy1naWxlYWQtbXlsYW4tbGVhZC13aXRoLWF1dGhvcml6ZWQtZ2VuZXJpYy1wbGF5LzU0OTc2MC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Aerie's eye drops win FDA approval,2019-03-13 00:00:00,https://news.google.com/./articles/CBMiZWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWVyaWUtcm9ja2xhdGFuLWV5ZS1hcHByb3ZhbC1pbnRyYW9jdWxhci1wcmVzc3VyZS1nbGF1Y29tYS81NTA0MjIv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Pharmas, PBMs and payers all take a slice along drug supply chain ...",2019-03-11 00:00:00,https://news.google.com/./articles/CBMidGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGhhcm1hcy1wYm1zLWFuZC1wYXllcnMtYWxsLXRha2UtYS1zbGljZS1hbG9uZy1kcnVnLXN1cHBseS1jaGFpbi1wZXctZmluZC81NTAyMDYv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Louisiana selects Gilead for subscription-based hep C program,2019-03-27 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbG91aXNpYW5hLWdpbGVhZC1zdWJzY3JpcHRpb24tbW9kZWwtaGVwYXRpdGlzLWMtZHJ1Z3MvNTUxNDI4L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Gilead raises prices on top-selling HIV treatments,2019-03-19 00:00:00,https://news.google.com/./articles/CBMiXWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZ2lsZWFkLXJhaXNlcy1wcmljZXMtb24tdG9wLXNlbGxpbmctaGl2LXRyZWF0bWVudHMvNTUwNzMzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Diabetes group nods to Vascepa, sending Amarin stock higher",2019-03-28 00:00:00,https://news.google.com/./articles/CBMiZWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZGlhYmV0ZXMtZ3JvdXAtbm9kcy10by12YXNjZXBhLXNlbmRpbmctYW1hcmluLXN0b2NrLWhpZ2hlci81NTE1MjUv0gEA?hl=en-US&gl=US&ceid=US%3Aen
GSK to invest $100M in Montana vaccine manufacturing site,2019-04-24 00:00:00,https://news.google.com/./articles/CBMiY2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZ3NrLXRvLWludmVzdC0xMDBtLWluLW1vbnRhbmEtdmFjY2luZS1tYW51ZmFjdHVyaW5nLXNpdGUvNTUzMzY1L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Atlas Venture caps 'superb venture return' on Arteaus with $260M ...,2019-04-01 00:00:00,https://news.google.com/./articles/CBMic2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYXRsYXMtdmVudHVyZS1jYXBzLXN1cGVyYi12ZW50dXJlLXJldHVybi1vbi1hcnRlYXVzLXdpdGgtMjYwbS1yb3lhbHR5LXNhLzU1MTczMy_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"GSK, AstraZeneca explore continuous manufacturing in partnership ...",2019-04-11 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZ3NrLWFzdHJhemVuZWNhLWNvbnRpbnVvdXMtbWFudWZhY3R1cmluZy1jcGkvNTUyNTU3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Astellas' AML therapy bests chemo in Phase 3 study,2019-04-02 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYXN0ZWxsYXMtYW1sLXRoZXJhcHktYmVzdHMtY2hlbW8taW4tcGhhc2UtMy1zdHVkeS81NTE4NTEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
AbbVie wins hep C contract with Washington state in latest 'Netflix ...,2019-04-26 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWJidmllLXdpbnMtaGVwLWMtY29udHJhY3Qtd2l0aC13YXNoaW5ndG9uLXN0YXRlLzU1MzU3Ni_SAQA?hl=en-US&gl=US&ceid=US%3Aen
German Merck finally gets yes for MS drug Mavenclad,2019-04-02 00:00:00,https://news.google.com/./articles/CBMiX2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbWVyY2sta2dhYS1tYXZlbmNsYWQtZmRhLWFwcHJvdmFsLW11bHRpcGxlLXNjbGVyb3Npcy81NTE3NTAv0gEA?hl=en-US&gl=US&ceid=US%3Aen
'Female Viagra' keeps alcohol black box warning amid FDA dispute ...,2019-04-12 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLXNwcm91dC1hZGR5aS1ib3gtd2FybmluZy1kZWNpc2lvbi1hbGNvaG9sLzU1MjY0MC_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Evotec to buy Just Biotherapeutics for up to $90M,2019-05-23 00:00:00,https://news.google.com/./articles/CBMiW2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZXZvdGVjLXRvLWJ1eS1qdXN0LWJpb3RoZXJhcGV1dGljcy1mb3ItdXAtdG8tOTBtLzU1NTQ2NS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Biologics license application submission: finding expert help,2019-05-28 00:00:00,https://news.google.com/./articles/CBMiaGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL3Nwb25zL2Jpb2xvZ2ljcy1saWNlbnNlLWFwcGxpY2F0aW9uLXN1Ym1pc3Npb24tZmluZGluZy1leHBlcnQtaGVscC81NTUzNDAv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Amylyx Pharmaceuticals Strengthens Leadership Team with the ...,2019-06-24 00:00:00,https://news.google.com/./articles/CBMi0AFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDE5MDYyNDAwNTQ0Ni9lbi9BbXlseXgtUGhhcm1hY2V1dGljYWxzLVN0cmVuZ3RoZW5zLUxlYWRlcnNoaXAtVGVhbS13aXRoLXRoZS1BcHBvaW50bWVudHMtb2YtQ2hpZWYtTWVkaWNhbC1PZmZpY2VyLUNoaWVmLUNvbW1lcmNpYWwtT2ZmaWNlci1hbmQtR2xvYmFsLUhlYWQtU3VwcGx5LUNoYWlu0gEA?hl=en-US&gl=US&ceid=US%3Aen
Amylyx Pharma Names Patrick Yeramian Chief Medical Officer,2019-06-24 00:00:00,https://news.google.com/./articles/CBMiYWh0dHBzOi8veGNvbm9teS5jb20vYm9zdG9uLzIwMTkvMDYvMjQvYW15bHl4LXBoYXJtYS1uYW1lcy1wYXRyaWNrLXllcmFtaWFuLWNoaWVmLW1lZGljYWwtb2ZmaWNlci_SAQA?hl=en-US&gl=US&ceid=US%3Aen
R&D leaders worry pharma reputation risks losing talent,2019-06-05 00:00:00,https://news.google.com/./articles/CBMiYGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmlvLTE5LXlhbmNvcG91bG9zLXJlc2VhcmNoLWxlYWRlcnMtYXR0cmFjdGluZy10YWxlbnQvNTU2MjYzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"Bluebird delays gene therapy launch to 2020, citing manufacturing ...",2019-06-18 00:00:00,https://news.google.com/./articles/CBMicmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmx1ZWJpcmQtZGVsYXlzLWdlbmUtdGhlcmFweS1sYXVuY2gtdG8tMjAyMC1jaXRpbmctbWFudWZhY3R1cmluZy10d2Vha3MvNTU3MTA3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
FDA warns Akorn on issues at New Jersey plant,2019-06-27 00:00:00,https://news.google.com/./articles/CBMiWGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLXdhcm5zLWFrb3JuLW9uLWlzc3Vlcy1hdC1uZXctamVyc2V5LXBsYW50LzU1Nzc4Mi_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Allergan reportedly hires Spark Foundry as US advertising agency,2019-06-12 00:00:00,https://news.google.com/./articles/CBMia2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYWxsZXJnYW4tcmVwb3J0ZWRseS1oaXJlcy1zcGFyay1mb3VuZHJ5LWFzLXVzLWFkdmVydGlzaW5nLWFnZW5jeS81NTY3NDkv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"ImmunoGen to lay off 220 workers, as it pushes ahead with troubled ...",2019-06-27 00:00:00,https://news.google.com/./articles/CBMicWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvaW1tdW5vZ2VuLXRvLWxheS1vZmYtMjIwLXdvcmtlcnMtYXMtaXQtcHVzaGVzLWFoZWFkLXdpdGgtdHJvdWJsZWQtZHJ1Zy81NTc3Nzkv0gEA?hl=en-US&gl=US&ceid=US%3Aen
CMS approves Louisiana's 'Netflix model' using Gilead hepatitis C ...,2019-06-26 00:00:00,https://news.google.com/./articles/CBMicmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvY21zLWFwcHJvdmVzLWxvdWlzaWFuYXMtbmV0ZmxpeC1tb2RlbC13aXRoLWdpbGVhZC1mb3ItaGVwYXRpdGlzLWMtZHJ1Z3MvNTU3NzA4L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Biohaven blames Apotex for FDA rejection of ALS drug,2019-07-22 00:00:00,https://news.google.com/./articles/CBMiX2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmlvaGF2ZW4tYmxhbWVzLWFwb3RleC1mb3ItZmRhLXJlamVjdGlvbi1vZi1hbHMtZHJ1Zy81NTkyMjgv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"FTC probing J&J on Remicade, as biosimilar market remains muted",2019-07-30 00:00:00,https://news.google.com/./articles/CBMiY2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZnRjLXByb2JlLWpvaG5zb24tcmVtaWNhZGUtYmlvc2ltaWxhci1tYXJrZXQtY29tcGV0aXRpb24vNTU5ODE3L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Arnold Schwarzenegger's planned cameo in 'The Predator' revealed,2019-07-15 00:00:00,https://news.google.com/./articles/CBMia2h0dHBzOi8vY2EubW92aWVzLnlhaG9vLmNvbS9hcm5vbGQtc2Nod2FyemVuZWdnZXJzLXBsYW5uZWQtY2FtZW8taW4tdGhlLXByZWRhdG9yLWlzLXJldmVhbGVkLTEyMDY1MzAyNi5odG1s0gFzaHR0cHM6Ly9jYS5tb3ZpZXMueWFob28uY29tL2FtcGh0bWwvYXJub2xkLXNjaHdhcnplbmVnZ2Vycy1wbGFubmVkLWNhbWVvLWluLXRoZS1wcmVkYXRvci1pcy1yZXZlYWxlZC0xMjA2NTMwMjYuaHRtbA?hl=en-US&gl=US&ceid=US%3Aen
"J&J moving forward with U.S. peds application for Xarelto, as Bayer ...",2019-07-10 00:00:00,https://news.google.com/./articles/CBMif2h0dHBzOi8vd3d3Lm1tbS1vbmxpbmUuY29tL2hvbWUvY2hhbm5lbC9qai1tb3ZpbmctZm9yd2FyZC13aXRoLXUtcy1wZWRzLWFwcGxpY2F0aW9uLWZvci14YXJlbHRvLWFzLWJheWVyLXByZXBzLWV1cm9wZWFuLWZpbGluZy_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Nabriva wins FDA's favor on pneumonia antibiotic,2019-08-20 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbmFicml2YS13aW5zLWZkYXMtZmF2b3Itb24tcG5ldW1vbmlhLWFudGliaW90aWMvNTYxMjgzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Anticholinergic Drug Exposure Is Associated with Dementia ...,2019-08-08 00:00:00,https://news.google.com/./articles/CBMidWh0dHBzOi8vam91cm5hbHMubHd3LmNvbS9uZXVyb3RvZGF5b25saW5lL2Z1bGx0ZXh0LzIwMTkvMDgwODAvYW50aWNob2xpbmVyZ2ljX2RydWdfZXhwb3N1cmVfaXNfYXNzb2NpYXRlZF93aXRoLjEuYXNweNIBAA?hl=en-US&gl=US&ceid=US%3Aen
Biogen stops Phase 2 study in another hit to 'high-risk' pipeline,2019-09-17 00:00:00,https://news.google.com/./articles/CBMiamh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvYmlvZ2VuLXN0b3BzLXBoYXNlLTItc3R1ZHktaW4tYW5vdGhlci1oaXQtdG8taGlnaC1yaXNrLXBpcGVsaW5lLzU2MzA3OS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Private equity firm to buy Sanofi's oldest plant in India,2019-09-12 00:00:00,https://news.google.com/./articles/CBMiZ2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2Fub2ZpLXNlbGwtb2xkZXN0LXBsYW50LWluZGlhLXByaXZhdGUtZXF1aXR5LWFkdmVudC16ZW50aXZhLzU2MjgwNS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Skyrizi looks ready to soar after strong launch,2019-09-04 00:00:00,https://news.google.com/./articles/CBMiZWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvc2t5cml6aS1hYmJ2aWUtcHJlc2NyaXB0aW9ucy1zYWxlcy1lc3RpbWF0ZXMtZ3Jvd3RoLWxhdW5jaC81NjIyMzEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Amylyx Pharmaceuticals Announces Last Patient Completes Last ...,2019-10-04 00:00:00,https://news.google.com/./articles/CBMirAFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDE5MTAwNDAwNTQyOC9lbi9BbXlseXgtUGhhcm1hY2V1dGljYWxzLUFubm91bmNlcy1MYXN0LVBhdGllbnQtQ29tcGxldGVzLUxhc3QtU3R1ZHktVmlzaXQtaW4tQ0VOVEFVUi1QaGFzZS0yLVN0dWR5LW9mLUFNWDAwMzUtaW4tQUxT0gEA?hl=en-US&gl=US&ceid=US%3Aen
FDA leaders worry agency will lose out on talent in gene therapy ...,2019-10-07 00:00:00,https://news.google.com/./articles/CBMiX2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLWNoYWxsZW5nZS1yZWNydWl0aW5nLWV4cGVydHMtZ2VuZS10aGVyYXB5LWNhbmNlci81NjQ1MDEv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Native ISI rich media: A prescription for the ultimate digital pharma ...,2019-10-10 00:00:00,https://news.google.com/./articles/CBMidmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL3Nwb25zL25hdGl2ZS1pc2ktcmljaC1tZWRpYS1hLXByZXNjcmlwdGlvbi1mb3ItdGhlLXVsdGltYXRlLWRpZ2l0YWwtcGhhcm1hLWNhbXBhLzU2NDM4NS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
Novartis backs away from marketing Pear digital therapeutics,2019-10-16 00:00:00,https://news.google.com/./articles/CBMiaGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92YXJ0aXMtc2FuZG96LWJhY2tzLW91dC1wZWFyLWRpZ2l0YWwtdGhlcmFwZXV0aWNzLW1hcmtldGluZy81NjUxNTUv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Parexel partners with Datavant on real-world data,2019-10-10 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvcGFyZXhlbC1kYXRhdmFudC1yZWFsLXdvcmxkLWRhdGEtcGFydG5lcnNoaXAvNTY0NzczL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Novartis' Zolgensma starts strong as about 100 infants are treated ...,2019-10-22 00:00:00,https://news.google.com/./articles/CBMiXGh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3Mvbm92YXJ0aXMtem9sZ2Vuc21hLXNtYS1nZW5lLXRoZXJhcHktc3Ryb25nLWxhdW5jaC81NjU1NDYv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Assessing provider (and patient) motivation,2019-10-23 00:00:00,https://news.google.com/./articles/CBMiVWh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL3Nwb25zL2Fzc2Vzc2luZy1wcm92aWRlci1hbmQtcGF0aWVudC1tb3RpdmF0aW9uLzU2NTQ3OS_SAQA?hl=en-US&gl=US&ceid=US%3Aen
"FDA approves new epilepsy therapy, a first for Korea's SK Life Science",2019-11-22 00:00:00,https://news.google.com/./articles/CBMiV2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZmRhLWFwcHJvdmFsLXhjb3ByaS1lcGlsZXBzeS1zay1saWZlLXNjaWVuY2UvNTY3ODk4L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
"5 updates from Teva's busy quarter: A new CFO, a biosimilar launch ...",2019-11-07 00:00:00,https://news.google.com/./articles/CBMibmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdGV2YS01LXVwZGF0ZXMtdGhpcmQtcXVhcnRlci1lYXJuaW5ncy1kZWJ0LWNhc2gtZmxvdy1ham92eS1jb3BheG9uZS81NjY4MzYv0gEA?hl=en-US&gl=US&ceid=US%3Aen
"Dicerna links up with Novo in its 5th, likely final, liver-focused R&D ...",2019-11-18 00:00:00,https://news.google.com/./articles/CBMiWmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvZGljZXJuYS1ub3ZvLW5vcmRpc2stZGVhbC1uYXNoLWRpYWJldGVzLW9iZXNpdHkvNTY3NTE4L9IBAA?hl=en-US&gl=US&ceid=US%3Aen
Lonza CEO Funk to step down after 9 months on job,2019-11-14 00:00:00,https://news.google.com/./articles/CBMiPmh0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvbG9uemEtY2VvLWRlcGFydHVyZS81NjczNjAv0gEA?hl=en-US&gl=US&ceid=US%3Aen
Amylyx Pharmaceuticals Announces AMX0035 Demonstrated ...,2019-12-17 00:00:00,https://news.google.com/./articles/CBMiwwFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDE5MTIxNzAwNTI0OC9lbi9BbXlseXgtUGhhcm1hY2V1dGljYWxzLUFubm91bmNlcy1BTVgwMDM1LURlbW9uc3RyYXRlZC1TdGF0aXN0aWNhbGx5LVNpZ25pZmljYW50LVRyZWF0bWVudC1CZW5lZml0LWZvci1QZW9wbGUtd2l0aC1BTFMtaW4tdGhlLUNFTlRBVVItVHJpYWzSAQA?hl=en-US&gl=US&ceid=US%3Aen
Amylyx Announces Appointment of Debra Canner as Global Head of ...,2019-12-12 00:00:00,https://news.google.com/./articles/CBMihwFodHRwczovL3d3dy5idXNpbmVzc3dpcmUuY29tL25ld3MvaG9tZS8yMDE5MTIxMjAwNTQ0NS9lbi9BbXlseXgtQW5ub3VuY2VzLUFwcG9pbnRtZW50LW9mLURlYnJhLUNhbm5lci1hcy1HbG9iYWwtSGVhZC1vZi1IdW1hbi1SZXNvdXJjZXPSAQA?hl=en-US&gl=US&ceid=US%3Aen
"Pete Frates, face of 'Ice Bucket Challenge,' dies after battle with ALS",2019-12-09 00:00:00,https://news.google.com/./articles/CBMiYmh0dHBzOi8vbnlwb3N0LmNvbS8yMDE5LzEyLzA5L3BldGUtZnJhdGVzLWZhY2Utb2YtaWNlLWJ1Y2tldC1jaGFsbGVuZ2UtZGVhZC1hZnRlci1iYXR0bGUtd2l0aC1hbHMv0gFmaHR0cHM6Ly9ueXBvc3QuY29tLzIwMTkvMTIvMDkvcGV0ZS1mcmF0ZXMtZmFjZS1vZi1pY2UtYnVja2V0LWNoYWxsZW5nZS1kZWFkLWFmdGVyLWJhdHRsZS13aXRoLWFscy9hbXAv?hl=en-US&gl=US&ceid=US%3Aen
Ultragenyx sells European royalty stake in rare disease drug for ...,2019-12-18 00:00:00,https://news.google.com/./articles/CBMiY2h0dHBzOi8vd3d3LmJpb3BoYXJtYWRpdmUuY29tL25ld3MvdWx0cmFnZW55eC1yb3lhbHR5LXBoYXJtYS1jcnlzdml0YS1ldXJvcGUtbGljZW5zaW5nLWRlYWwvNTY5MzQzL9IBAA?hl=en-US&gl=US&ceid=US%3Aen
